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Summary  
Widespread use of antibiotics leads to development of antimicrobial resistance, an 
increasing threat to health worldwide. The strategy of delayed antibiotic prescribing 
reduces antibiotics use for respiratory tract infections (RTIs) in experimental settings. 
The overall aim of this thesis is to explore delayed antibiotic prescribing and its 
potential in reducing antibiotic use for RTIs in routine primary care. 
In a Norwegian primary care setting, we did 1) a controlled trial among GPs on 
the antibiotics saving effect of recommending delayed prescribing through 
lectures/group discussion and through a computerised pop-up reminder, 2) a 
qualitative study among GPs, and 3) a questionnaire study among GPs issuing and 
patients receiving delayed prescriptions. 
We found that GPs regard delayed prescribing as an acceptable strategy for 
reserving antibiotics to the cases where it turns out to be medically indicated, 
especially acute otitis and acute sinusitis. GPs have strict requirements as to which 
patients, for which diagnoses and in which situations they will issue delayed 
prescriptions, resulting in an infrequent use of the strategy. GPs who received the 
interventions issued 11% of the antibiotic prescriptions as delayed prescriptions, and 
59% of these were dispensed from pharmacies. The interventions gave a statistically 
significant but clinically modest decrease (RR 0.97) in dispensed antibiotics, without 
any accompanying increase in prescribed antibiotics. 
The use of delayed prescribing should be encouraged as a tool to adhere to 
treatment guidelines, especially in cases of acute otitis and acute sinusitis. Interventions 
to promote its use have little effect, and pop-up reminders are not to recommend as a 
sole intervention, but should be considered as part of multi-faceted interventions. 
Delayed prescribing’s potential in reducing antibiotic use seems to be low in our 
setting, presumably because of relatively low antibiotic prescribing rates and low 
patient expectation for antibiotics. The strategy’s potential should be assessed in 
advance of interventions to implement its use. Further research should focus on the 
clinical outcomes of delayed prescribing for acute sinusitis, and the effect of other 
intervention elements in the implementation of delayed prescribing.   
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Norsk sammendrag (Summary in Norwegian) 
Utbredt antibiotikabruk fører til antibiotikaresistens, som er en økende helsetrussel 
over hele verden. I eksperimentelle studier medfører forskrivning av vent-og-se-resept 
redusert antibiotikabruk ved luftveisinfeksjoner. Det overordnede målet med denne 
avhandlingen er å utforske vent-og-se-resept-strategien og dens evne til å redusere 
antibiotikabruken ved luftveisinfeksjoner i allmennpraksis. 
Vi gjennomførte tre studier i norsk allmennpraksis: 1) en kontrollert studie av 
den antibiotikasparende effekten av å anbefale vent-og-se-resept for allmennleger 
gjennom forelesning/gruppediskusjon og gjennom en pop-up-påminner på legens 
dataskjerm, 2) en kvalitativ undersøkelse blant allmennleger, og 3) en 
spørreskjemaundersøkelse blant allmennleger og pasienter. 
Vi fant at allmennlegene ser på vent-og-se-resept som en akseptabel strategi for å 
forbeholde antibiotika til de tilfeller der det viser seg å bli medisinsk indisert, spesielt 
ved akutt mellomørebetennelse og akutt bihulebetennelse. Allmennleger har strenge 
krav til hvilke pasienter, ved hvilke diagnoser og i hvilke situasjoner de vil gi vent-og-
se-resept, noe som resulterer i at strategien sjelden brukes. Legene som mottok begge 
intervensjonene gav 11% av antibiotikareseptene som vent-og-se-resept, og 59% av 
disse ble uthentet fra apotek. Intervensjonene gav en statistisk signifikant, men klinisk 
beskjeden reduksjon (RR 0,97) i utlevert antibiotika, uten noen medfølgende økning i 
forskrevet antibiotika. 
Bruk av vent-og-se-resept bør anbefales som et hjelpemiddel til å følge 
behandlingsretningslinjene, spesielt ved mellomørebetennelse og bihulebetennelse. 
Våre tiltak for å øke bruken av vent-og-se-resept har sparsom effekt. En pop-up-
påminner anbefales ikke brukt alene, men bør inkluderes i sammensatte 
kvalitetsforbedringsprosjekter. Vent-og-se-strategiens antibiotikasparende potensial 
synes å være lav i vår sammenheng, antagelig på grunn av den relativt lave 
forskrivningsraten og pasientenes lave forventning om å få antibiotika i Norge. 
Strategiens potensial bør vurderes i forkant av tiltak for å øke bruken av den. Videre 
forskning bør fokusere på klinisk utfall av vent-og-se-resept ved akutt 
bihulebetennelse, og på effekten av andre tiltak for å øke bruken av vent-og-se-resept. 
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Introduction 
Penicillin was discovered by Alexander Fleming in 1928, and made available for 
patients during The second world war. It was the first really effective medical 
treatment for bacterial infections, and marked the transition to a new era in medicine – 
an era characterised by powerful and effective chemicals. Penicillin was nicknamed 
“the magic bullet”, and it made people believe that the fight aginst infectious diseases 
was won once and for all (1). 
However, already in his Nobel Lecture in 1945, Alexander Fleming said: “The 
time may come when penicillin can be bought by anyone in the shops. Then there is 
the danger that the ignorant man may easily underdose himself and by exposing his 
microbes to non-lethal quantities of the drug make them resistant. Here is a 
hypothetical illustration. Mr. X. has a sore throat. He buys some penicillin and gives 
himself, not enough to kill the streptococci but enough to educate them to resist 
penicillin. He then infects his wife. Mrs. X gets pneumonia and is treated with 
penicillin. As the streptococci are now resistant to penicillin the treatment fails. Mrs. X 
dies. Who is primarily responsible for Mrs. X’s death? Why Mr. X whose negligent use 
of penicillin changed the nature of the microbe.” (2) 
Evidently the fight aginst infectious diseases is not won, partly because of 
antimicrobial resistance, caused by the ecological side effects of the magic bullet itself. 
Even though Flemings moral – “If you use penicillin, use enough” (2) – may not be 
directly applicable in our context, he foresaw some major problems in the times to 
come: patients preference for antibiotics, widespread and “ignorant” use of antibiotics, 
treatment failure due to resistance, and the moral dilemma of using up the effect of 
antibiotics on minor illnesses at the expence of severe illnesses.   
In our time, Flemings conclusion could be rewritten: “If you use penicillin, you 
are presumably in Scandinavia”. Due to the relatively low levels of antibiotic 
resistance, old-fashioned phenoxymethylpenicillin is still the most used antibiotic in 
primary care in the three Scandinavian countries(3, 4). An overall aim must be to 
maintain the low levels of resistance, through a responsible and sustainable use of 
antibiotics.  
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For antibiotics to cause an ecological – and therapeutical – effect, a chain of 
events must occur. In the primary care setting, the typical chain is as follows: a person 
must have some sort of complaint, the person must choose to see a doctor for this 
complaint, the doctor must choose to give a prescription for an antibiotic, which the 
person must choose to pick up at a pharmacy, and finally, choose to consume. The 
chain may be broken or modified at all the stages; eg immunisation may alter the 
incidence of infectious diseases, public campaigns may alter peoples health seeking 
behaviour, educational interventions may influence on the doctors prescribing habits, 
and last but not least – efforts may affect whether the patient fills the prescription 
and/or consumes the antibiotics. This thesis will explore the strategy of delayed 
prescribing, and its ability to modify this last event in the chain.  
 
Antimicrobial resistance 
Antimicrobial resistance is the ability of a microorganism to resist the action of an 
antimicrobial agent. In clinical medicine, the most common and worrisom form of 
antimicrobial resistance is antibiotic resistance; bacteria resistant to the action of an 
antibiotic. The resistance may be natural, as with bacteria naturally lacking the specific 
molecules attacked by certain antibiotics, or acquired, through the processes of 
adaptation by genetic change. In the presence of an antibiotic, resistant bacteria will 
grow and multiply, while susceptible bacteria will be killed. Resistance genes transfer 
to the offspring and may also spread to other bacteria species. The emergence of 
antibacterial resistance is a natural consequense of exposing bacteria to an antibiotic 
environment.  
The challenge of antimicrobial resistance is increasing worldwide. The European 
Centre for Disease Prevention and Control points especially at the increasing trend of 
combined resistance to several antimicrobials in Escherichia coli, Pseudomonas 
aeruginosa and Klebsiella pneumoniae, and the high levels of meticillin-resistant 
Staphylococcus aureus (MRSA) (5). 
The levels of antimicrobial resistance are considerably lower in Norway 
compared to most other European countries (6). While the rate of invasive 
Staphylococcus aureus-isolates with resistance to meticillin in 2011 were above 25% in 
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Portugal, Italy and Greece, and between 10% and 25% in most other European 
countries, the rate in Norway and Sweden was below 1%. Although antimicrobial 
resistance is still regarded a limited problem in Norway (7), the problem is increasing. 
For instance, the number of MRSA infections, the levels of ESBL producing E. coli 
and Klebsiella spp. and the level of beta-lactamase producing H. influenza are rising.   
Antimicrobial resistance leads to suffering, prolonged illness, higher healthcare 
expenditures and death. An estimated 25.000 annual deaths in Europe are said to be 
caused by multiresistant infections (8).  
The relationship between the use of antimicrobial agents and the appearance of 
antimicrobial resistance is well established through observational studies. Areas with 
high consumption of antibiotics also have high levels of antibiotic resistance (9), and a 
decrease in antibiotic consumption leads to lower levels of resistance (10, 11). 
Randomised controlled trials have proven this relationship to be causal at both the 
individual (12, 13) and the community (14) level.  
In the first half century of the antibiotic era, several new types of antibiotics were 
discovered. Thus, if one type of antibiotics did not work, there was always a new type 
that would. However, the development of new antimicrobial agents is declining (15). 
Modern strategies to discover new antibiotics have not succeeded (16), and since 1987 
no antibiotics with new modes of action have been found (17). In this situation, the 
two major strategies to withstand the challenges of antimicrobial resistance are: 1) 
Minimising the use of antibiotics. 2) Hygienic actions against spread of resistant 
bacteria. 
However, the overall trend is an increased use of antibiotics, both globally and in 
Norway. European outpatient antibiotic use increased by 0,05 defined daily doses pr 
1000 inhabitants pr day (DID) quarterly from 1997 to 2009 (3). In Norway, there was 
a 16% increase in total sales of antibiotics in humans, defined as DID (excluded 
methenamine) from 2004 to 2011 (7). 
 
Antibiotics for RTIs in primary care 
In the early days of the antibiotic era, the medication was used to heal life threatening 
infections. Antibiotics soon won large popularity both among doctors and patients, 
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and the indication for use was extended (1). Today, antibiotics are most often used to 
shorten and relieve symptoms of mild and self-limiting respiratory tract infections 
(RTIs). In Norway, 84% of the total human sales of antibacterials in 2011 were used 
outside institutions, mainly prescribed by general practitioners (7). Straand et al. found 
that respiratory tract infections represented more than half of the prescribed 
antibiotics in Norwegian general practice (18). Similar numbers are found in the UK 
(19). In a recent study from Norwegian primary care (20), Gjelstad et al. demonstrated 
that 60% of patients who consulted their general practitioner for bronchitis were 
prescribed antibiotics. The corresponding rate for sinusitis was 74%. Alltogether, 
antibiotics were prescribed in one third of the RTI episodes. An European 
observational study, collecting data from general practice in 13 countries, found a 53% 
antibiotic prescription rate for bronchitis/acute cough (21).  
This level of antibiotic prescribing contrasts the evidence from meta-analyses 
that antibiotics give only a modest, if any, benefit in most respiratory tract infections. 
In acute bronchitis, a Cochrane review found that the benefit of antibiotics is half a 
day shortening of cough (22). The reviewers conclude that the magnitude of benefit is 
similar to that of the detriment from potential adverse effects. In acute sinusitis, a 
Cochrane review states that 80% of patients given placebo improve within two weeks, 
compared to 90% in the antibiotics groups. The authors guide clinicians to weigh the 
small benefits of antibiotics with the potential for adverse effects. For the common 
cold or purulent rhinitis, there is no benefit of antibiotics (23). Among children with 
acute otitis media, 15 patients must be treated with antibiotics to prevent one child 
from having some pain after two days (24). Again, the reviewers state that the small 
benefit provided by antibiotics must be weighed against the possible adverse reactions.  
There are wide variations in antibiotics prescribing rates both between individual 
GPs and between countries. Gjelstad et al (25) found that among Norwegian general 
practitioners, the quintile of GPs with the highest antibiotics prescription rate for 
RTIs prescribed antibiotics three times as frequently as the quintile with the lowest 
prescription rate. Goossens et al (9) have demonstrated that within Europe, outpatient 
antibiotic use is three times higher in the highest consuming country compared to the 
lowest consuming country.  
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These factors establish the fact that a vast number of primary care patients with 
respiratory tract infections receive and consume antibiotics without any substantial 
benefit from it. Allthough the classes of antibiotics most commonly prescribed for 
RTIs in primary care are not the worst in promoting resistent bacteria strains, the large 
volume of antibiotics consumed makes this area a strong driving force for bacterial 
resistance (19). Hence, RTIs in primary health care is a prioritised area when trying to 
reduce antibiotics consumption.  
Using antibiotics for conditions in which it has only marginal or no clinical effect 
has been labelled unnecessary or inappropriate antibiotic use or antibiotic overuse or misuse 
(19), and the conditions in question have been labelled self-limiting (26).  
However, at the individual patient level, the question of whether an antibiotic for 
a mild RTI is necessary and appropriate may not be clear cut. The decision involves 
balancing different aspects of a situation, and may be elucidated by referring to ethical 
principles. Beauchamp and Childress (27) pinpoint four main principles within medical 
ethics, all of them relevant in the decision whether to prescribe antibiotics for RTIs; 
autonomy, non-malificience, beneficence and justice. The RTI patient may demand a 
certain treatment, and his or her autonomy should be respected. However, 
unneccessarry treatment with a potent drug that has both individual and societal side 
effects is malificient. Still, the patient might have a chance, though small, that antibiotics 
may shorten the illness or prevent complications, hence be beneficial to the patient. If 
this is true, then one has to weigh the justice in a benefit for this patient towards an 
increased risk of infections caused by resistant bacteria in another patient, like the case 
of Flemings mr. and mrs X. 
Hence, when a GP prescribes antibiotics for a patient with a RTI, he or she most 
likely find it necessary at some level. In a recent systematic review of qualitative 
research on GPs’ views and experiences of antibiotic prescribing, Tonkin-Crine et al 
(28) found that GPs were most satisfied with their prescribing decision if the different 
influencing factors, e.g. guidelines and patient’s wishes, were in agreement. Still, GPs 
might choose to give priority to patients’ wishes over guideline advice, and feel 
satisfied after having made this choice. The authors state that “…satisfaction with a 
decision does not necessarily relate to whether or not a decision is appropriate, but 
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whether the GP believes it is appropriate.” Through qualitative research, GPs’ reasons 
for prescribing antibiotics for RTIs has been explored. Petursson (29) found that GPs 
in Iceland listed several reasons for so-called non-pharmacological prescribing; 
Physician’s insecurity, uncertainty or anxiety, pressure from patients and their families, 
work pressure and fatigue, the physician’s personal character, and organisational 
factors. The author conclude that when practicing the three objectives of medicine – 
to cure, to relieve suffering, and to provide comfort – a biomedically inappropriate 
prescription still may be medically rational in the process of winning the patient’s 
confidence and trust. 
Hence, being aware of the lacking or modest effect of antibiotics for RTIs does 
not necessarily prevent GPs from prescribing. The different reasons for non-
pharmacological antibiotic prescribing may roughly be divided into two factors (30): 1) 
Patient related factors, such as expectations for antibiotics, and 2) Prognostic 
uncertainty. A tool or strategy that might help GPs in the decision whether to 
prescribe, resulting in less antibiotics consumption, should preferrably address both 
these factors. One such strategy is delayed prescribing. 
 
Delayed prescribing 
Definition 
Delayed prescribing refers to a strategy in which patients are given access to a 
prescription for antibiotics together with an advice to wait for a certain amount of 
time before deciding whether to start on the antibiotics or not. The prescribing doctor 
may explain more or less thoroughly the criteria that should govern the patient’s 
decision, most commonly to start if the symptoms persist or deteriorates. The patient 
may get the prescription at the first visit, or be asked to come back to the doctor’s 
office and pick it up. The strategy is advocated and studied in cases of potentially self 
limiting infections, most commonly respiratory tract infections. It may be seen as a 
middle ground between prescribing an antibiotic to be taken immediately, and no 
antibiotics prescribing – leaving the patient to re-consult if needed.  
The strategy is most commonly referred to as “delayed prescribing”, but various 
other terms have been used, partly reflecting the different views on and explanations 
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for the strategy; “wait-and-see-prescription” (31), “deferred prescribing” (32), “back-
up antibiotic prescription” (33, 34), “back-pocket prescription” (35), “as-needed 
antibiotic prescription” (36, 37), and “safety-net antibiotic prescription” (38, 39). The 
terms watchful waiting and active expectancy may include delayed prescribing, but is a 
broader term of active follow up after (usually) an initial no-treatment consultation. 
GPs may have their own concepts of the strategy, such as “Friday prescriptions” (40), 
reflecting the notion of professor Bruce Arroll that “…physicians have spontaneously 
and independently generated the practice of delayed prescribing.” (41) The first notion 
of the concept in Norwegian medical literature was in an editorial on childhood acute 
otitis media in Tidsskrift for Den norske legeforening in 2002 (42). 
The delayed prescribing strategy is a primary care strategy; it is based on 
empirical treatment where the etiology of the infection is unknown. Also, the strategy 
depends on a consultation visits setting, as opposed to a hospital setting. The research 
on delayed prescribing mostly comes from general practice research institutions in 
countries with a strong and well developed primary health care service (43), with the 
exception that much research on delayed prescribing for acute otitis media is done in a 
pediatric setting. 
Delayed prescribing requires that the prescribing GP permits the patient to 
decide whether or not to consume the antibiotics. Three broad models of decision-
making in the clinical encounter have been described (44, 45): 1) The paternalistic 
model, in which the doctor decides what he thinks is best for the patient, without 
eliciting the patient’s preferences. 2) The informed choice model, in which the patient 
is informed about the choices she/he has to make her/himself. 3) The shared 
decision-making model, in which both patient and doctor contribute to the final 
decision. Delayed prescribing may fit into both the two last models. The strategy has 
been associated with the shared decision-making model (46, 47), however, delayed 
prescribing is a clinical tool rather than a communication method, and it has been 
warned that delayed prescribing should not substitute shared decision-making (48).  
 
Efficacy in clinical trials 
In 1997, the first randomised, controlled trial on delayed prescribing was conducted, 
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to evaluate the safety of the strategy. Little et al (49) evaluated three prescribing 
strategies in managing sore throat; antibiotics to be taken immediately, no antibiotics, 
and delayed antibiotics to be taken if the symptoms were not starting to settle after 
three days. Except duration of fever, they found no significant group differences in 
illness duration, days off work or school, or proportion of patients satisfied. In the 
immediate antibiotics group, 99% of the patients used antibiotics, compared to 13% in 
the no antibiotics group and 31% in the delayed antibiotics group.  
Later, similar trials have been conducted on patients with other respiratory tract 
infections, summarised in a Cochrane review (43). Two trials on lower respiratory tract 
infections/cough (50, 51) found no clinical difference in patients given delayed or 
immediate antibiotics. Antibiotics were used by 20% (51) – 45% (50) of the patients in 
the delayed prescribing group. Arroll et al evaluated delayed prescribing in the 
common cold (41), finding no difference in symptom score between delayed and 
immediate antibiotics. In the delayed prescription group, 48% reported to consume 
antibiotics, compared to 89% in the immediate prescription group. In three trials on 
childhood acute otitis media (31, 52, 53), the delayed prescriptions were used by 24% 
(53) – 38% (31, 52) of the patients, compared to 87% of the patients in the immediate 
antibiotics group (31, 53). Two of the studies compared delayed prescribing with 
immediate prescribing, the third compared delayed prescribing with no initial 
prescribing. Among the first two studies, Little et al (53) found more severe symptoms 
at day three in the delayed prescribing group but no significant differences at day 
seven, while Spiro et al (31) found no significant difference in symptoms between the 
two groups.  
Adverse effects were similar in both the immediate, delayed and no antibiotics 
groups, except for a small reduction in diarrhoea in the delayed antibiotics groups for 
children with acute otitis media (43). 
To our knowledge, the clinical outcomes of delayed prescribing for acute 
sinusitis has not been evaluated in randomised, controlled trials. A questionnaire study 
(34) concluded that delayed prescribing has the potential to reduce antibiotic use also 
for this condition.    
Most of the RCTs on delayed prescribing also evaluated patients’ satisfaction 
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with the different prescribing strategies. Overall, 87% of the participants in the delayed 
antibiotics groups were satisfied, compared to 92% in the immediate antibiotics 
groups and 83% in the no antibiotics groups.  
Delayed prescribing may reduce patients belief in the necessity of antibiotics for 
RTIs, reducing patients consultation rate for similar symptoms in the future . The 
Cochrane review states that patients intention to re-consult is lower when receiving a 
delayed prescription rather than immediate antibiotics, but finds no reduced re-
consultation rate in the delayed prescribing groups. However, a study focusing on re-
consultation rates (54) found that patients more often re-consulted with sore throat if 
earlier given immediate antibiotics rather than delayed or no antibiotics. The re-
consultation rate was lower, though insignificantly, in the delayed compared to the no 
antibiotics group. Similar results were found in a study on re-consultations for lower 
RTI (55). 
The trials on delayed prescribing have used different ways of delaying; either the 
prescription has been kept at the reception to be picked up, or it has been issued to 
patients during the consultation, with instructions to delay. The first method resulted 
in a significantly lower pick-up rate of 28% compared to 40% using the second 
method (43). This indicates that the effort required to obtain antibiotics strongly 
influences the patients’ behaviour. Postdating the delayed prescription, i.e. dating the 
prescription two days later than the date of the consultation so that the patient, in 
theory, will be unable to use it immediately, does not seem to influence on dispensing 
rate (56). 
Overall, the efficacy of delayed prescribing, in terms of decreased antibiotics 
consumption, is well proven and would be clinically significant if transferred to daily 
clinical practice. The patient safety and satisfaction are in line with immediate 
antibiotics.  
 
Effectiveness in routine care 
Although the efficacy of delayed prescribing is well proven in clinical trials, the 
effectiveness concerning diminished antibiotics use in routine care is not sufficiently 
explored.  
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It has been suggested that the first trial on delayed prescribing as an antibiotics 
saving strategy in 1997 had great impact on British GPs, explaining the increasing 
difference between prescribed and dispensed antibiotics for children in England in the 
years following 1997 (57). Compared to the 1993 level, by 2003 prescribed antibiotics 
had fallen by 37%, while dispensed antibiotics fell by 47%. This equals that 16% of the 
antibiotics prescriptions for children in 2003 were not dispensed at pharmacies. In 
1997, a British practice changed their management policy of childhood otitis media, 
from routine antibiotics prescribing to delayed prescribing, resulting in a decreased 
antibiotics use for all childhood infections by one fifth (58). The effect of the changed 
policy sustained (59). However, in two qualitative studies on delayed prescribing in 
Britain (60, 61), GPs inform that although delayed prescribing is well known, they 
seldom use the strategy. In a British survey by Edwards et al (32), about 10 % of 
patients presenting with RTIs were issued a delayed prescription. The immediate 
antibiotics prescription rate for the remaining 90 % was not recorded, precluding an 
estimation of the real incidence of delayed prescribing.  
In a New Zealand telephone survey published in 2000, the majority of the 
participating GPs estimated that less than 10% of their antibiotics prescriptions for 
RTIs would be delayed prescriptions (36). Five years later, 39% of the GPs reported to 
have increased their use of delayed prescribing (37, 62), owing partly to awareness of 
research on the topic (62). Twelve percent of the GPs reported to have decreased their 
use of delayed prescribing. However, these studies did not measure the actual use of 
delayed prescribing.  
A German direct observation study of primary care consultations for RTIs, 
published in 2005, found no use of delayed prescribing in the included 273 cases (63).  
An observational study by Francis and co-workers on the management of acute 
cough among adults in primary care, covering 14 networks in 13 European countries 
(64), is so far the largest study on delayed prescribing in routine care across Europe. 
The study comprised 3368 consultations for lower RTI, of which 6.3% resulted in a 
delayed prescription and 46.5% in an immediate prescription. 44.4% of those 
prescribed delayed antibiotics consumed the antibiotic, and an additional 10.7% used 
an antibiotic other than the one prescribed at the index consultation during the follow-
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up period. Two thirds of the patients consuming their delayed antibiotics started the 
course without any delay. 71.5% of the patients receiving a prescription for antibiotics 
to be taken immediately, consumed antibiotics in the study period. There were wide 
variations between the networks in the use of delayed prescribing, from 0.2% of the 
consultations in Barcelona to 33.1% in Southampton, with four networks using 
delayed prescribing in more than five percent of the consultations. Likewise, when 
prescribing antibiotics, the advice to delay was given in 11.8% of the cases, ranging 
from 3.5% (Barcelona) to 53% (Southampton). Also, both antibiotic prescribing rates 
and patients’ antibiotic consumption rates varied greatly between the networks.  
The study shows that delayed antibiotics prescribing for adults with cough is 
used infrequently across Europe. It also states that for delayed antibiotics, the 
consumption rate in routine care is higher than what is found in trials. In addition, the 
study reveals that patients are not adherent neither when told to delay nor when told 
to start on antibiotics immediately. The non-adherence to immediate prescriptions 
constitutes 13 times as many unused antibiotics courses compared to the antibiotics 
unused due to delayed prescribing.  
The included networks were small, and the GPs and patients may have been 
influenced by local circumstances (64). Also, the study dealt solely with adults with 
cough. Acute bronchitis is listed as number 7 and cough as number 9 by New Zealand 
GPs when asked for which symptoms and signs they would give a delayed prescription 
(62), and a small Canadian study shows that delayed prescriptions are given more 
frequently to patients with the diagnoses URTI and sinusitis than bronchitis (56). 
Hence, a lot of areas concerning the effectiveness of delayed prescribing in routine 
care were not explored in the study. 
A concern regarding delayed prescribing in routine care is that the 
implementation of the strategy would lead GPs to prescribe antibiotics more readily 
(50), possibly implying that implementation of delayed prescribing would lead to more, 
rather than less, antibiotics consumption. If the previously mentioned reduction in 
dispensed antibiotics for children seen in Britain following dissemination of research 
on delayed prescribing (57) is caused by GPs’ increased use of the strategy, this 
concern is unjustified. However, there may be other explanations for this reduction. In 
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the same time period, the consultation rate for RTIs among children decreased 
substantially (65), possibly because of increased parental scepticism towards 
antibiotics. The same cause may have led to an increased medication non-adherence, 
giving rise to the observed decrease in antibiotic dispensing rate. Based on the current 
knowledge, we do not know the effect on antibiotics consumption of implementing 
delayed prescribing in routine primary care. 
 
Experiences and opinions 
When this PhD-project was planned (2006), two qualitative studies on GPs’ views on 
and experiences with delayed prescribing for RTIs had been published. Arroll and co-
workers (66) found that a selection of New Zealand general practitioners regarded the 
strategy useful in decreasing unnecessary antibiotic use, empowering patients and 
strengthening physician–patient relationships, and that it might be convenient for 
patients. The GPs were selective concerning which patients they offered delayed 
prescriptions, but no common criteria were detected. Kumar and co-workers (60) 
explored why general practitioners prescribe antibiotics for sore throat, and found that 
delayed prescribing generally was regarded positively, although few described using it.  
Recently, a new study on prescribers’ views on delayed prescribing (61) revealed 
that a selection of UK GPs and nurse practitioners preferred reconsultation rather 
than delayed prescribing. They used the strategy unfrequently, foremostly to manage 
diagnostic uncertainty but also to avoid conflict. The prescribers felt uncomfortable 
leaving clinical responsibility to patients, and the authors concluded that alternative 
ways of communicating empathy, addressing patient beliefs and encouraging self-
management should be encouraged. 
Among leading researchers on delayed prescribing, there can be found two 
somewhat diverging views on the rationale behind the strategy – in addition to 
reducing antibiotics consumption – addressing the two main reasons for inappropriate 
antibiotics prescribing; (perceived) patient expectation and prognostic uncertainty.  
New Zealand professor and general practitioner Bruce Arroll and co-workers at 
The University of Auckland argue that ”Their [delayed prescriptions’] use should be 
restricted to those patients who request antibiotics or whom their doctor thinks they 
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want an antibiotic yet does not think one is immediately indicated.” (35), hence 
emphasising the ethical principle of autonomy. This is reflected by Arroll et al’s trial on 
delayed prescribing for the common cold (67), a condition for which antibiotics in 
principle are not medically indicated. Patients were included in the trial if “the [Family 
Practitioner] thought the patient wanted antibiotics or the patient stated that desire”. 
The authors conclude that delayed prescribing “has the potential to provide gentle 
education that antibiotics are an unnecessary treatment.”. The final aim of the strategy 
is to teach the patients not to demand antibiotics inappropriately, making delayed 
prescribing redundant. 
 Another view emphasises the prognostic uncertainty in RTIs. Professor Paul 
Little at The University of Southampton, UK, argues that some patients will end up 
with long lasting or complicated infections if not treated with antibiotics, but for now, 
there are no precise criteria that can predict who these patients are. In these cases, 
delayed prescribing serves as a “safety net” or a “backup plan” (68, 69), hence 
emphasising the principle of beneficence. Accordingly, Little and co-workers have 
conducted trials on delayed prescribing for conditions that may have a bacterial 
etiology, for which antibiotics may be medically indicated, eg. sore throat (49) and 
acute otitis media (53).  
Opposing these proponents’ views, the authors of the Cochrane review on 
delayed prescribing point out that delayed prescribing has no clinical advantages over 
no prescribing, and that the latter leads to lower antibiotics consumption. They 
encourage research on how both patients and doctors better can cope with a “no 
antibiotics” regimen (43). 
 
Delayed prescribing in guidelines 
As a response to the increasing antimicrobial resistance and overprescribing of 
antibiotics, many countries have developed national guidelines on antibiotic 
prescribing for RTIs in primary health care. Due to the promising findings in 
controlled trials, the different guidelines have, to a varying degree, included 
recommendation of delayed prescribing. The UK’s National Institute for Health and 
Clinical Care (NICE) guideline “Respiratory tract infections – antibiotic prescribing” 
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(26) of 2008 is the guideline that goes farthest in recommending delayed prescribing. 
Here, delayed antibiotic prescribing and no antibiotic prescribing are equivalent 
alternatives for patients with all kinds of “self-limiting respiratory tract infections”, 
unless the patient is at risk of developing complications.  
Among the Nordic countries, Norwegian guidelines for antibiotics use in 
primary health care (70), published in 2008, recommend delayed prescribing for all 
mild RTIs that might have a bacterial etiology, under certain circumstances. In 
Sweden, the guidelines on treatment of acute otitis media (71) from 2010 suggests 
delayed prescribing if a revisit is difficult. Also, the guidelines on treatment of lower 
respiratory tract infections (72) from 2008 suggests that the GP could consider delayed 
prescribing if it is difficult to distinguish between bronchitis and pneumonia. Neither 
Danish (73) nor Finnish (74) guidelines on the treatment of RTIs mention delayed 
prescribing.  
 
Changing GPs’ prescribing 
As GPs have the key role in regulating the amount of consumed antibiotics for RTIs 
in primary care, numerous interventions have been carried out to decrease GPs 
prescribing of antibiotics. Existing evidence prior to the onset of this study indicated 
that large effects of interventions to improve clinical practice were rare.  (75, 76). 
Passive dissemination of clinical practice guidelines showed only marginal or no 
effects on practice (77). More active interventions such as educational outreach visits 
(78), audit and feedback (79), and multi-faceted interventions (75) were found to be 
more effective. Computer-based reminder systems also showed promising effects (75).  
Newer reviews limited to antibiotic prescribing in an outpatient setting 
confirmed much of these results; interactive educational meetings were more effective 
than lectures, and multi-faceted interventions were the most successful in reducing 
antibiotic prescribing (80). However, educational outreach as well as reminder systems 
alone produced mixed results (80). Strategies that targeted the management of a single 
age group or infectious disease were less effective than strategies with broader 
inclusion criteria (81).  
A recent review restricted to physician-targeted interventions to improve 
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antibiotic use for respiratory tract infections (82) concluded that such interventions 
generally are effective, with an overall reduction in antibiotic prescribing of 11.6%. 
Again, it was found that multiple interventions were more frequently effective than 
interventions using only one element.  
We are not aware of reported intervention studies aimed at increasing GPs’ use 
of delayed prescribing. Studies evaluating interventions to improve GPs’ antibiotic 
prescribing habits generally measure the amount of prescribed and not dispensed 
antibiotics, thereby ignoring any use of delayed prescribing. A large educational 
intervention study in the UK (83) aimed to reduce antibiotic dispensing in primary 
care. The authors argue that compared to prescribed antibiotics, dispensed antibiotics 
is a better proxy for consumed antibiotics, due to the increasing use of delayed 
prescribing in the UK. However, the intervention did not include any promotion of 
delayed prescribing.  
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Aims of the study 
The overall aim of this thesis is to explore delayed antibiotic prescribing and its 
potential in reducing antibiotic use for RTIs in routine primary care. The thesis 
comprises three studies, each with specific aims: 
 
1. To measure the effects of a GP educational intervention and a computer 
delayed-prescribing pop-up reminder on antibiotic-dispensing rates. 
Secondary aim: to identify factors influencing GPs’ decisions to issue delayed 
prescriptions for RTIs and patients’ decisions to fill their prescriptions. (The 
intervention study) 
2. To explore GPs’ views on and experiences with delayed prescribing in 
patients with RTIs. (The focus group study) 
3. To explore GPs use and patients filling of delayed prescriptions for RTIs, 
and to investigate the feasibility of the strategy from GPs’ and patients’ 
perspective. (The questionnaire study) 
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Material and methods 
This thesis comprises three studies: The intervention study, the focus group study and 
the questionnaire study. The intervention study is an integrated part of the 
Prescription Peer Academic Detailing (Rx-PAD) study; it shares the design, 
participants, randomisation, data handling, sample size, ethics, data security and key 
elements of the intervention with the Rx-PAD study. Also, the participants in the 
focus group study and most of the participants in the questionnaire study took part in 
the Rx-PAD study. Therefore, this chapter starts with a presentation of the Rx-PAD 
study. 
 
Context: The Rx-PAD study 
Design  
Cluster-randomised controlled trial. The clusters were existing peer Continuous 
Medical Education (CME) groups. The groups were randomised to receive either a 
tailored intervention to support a more rational antibiotic prescribing for respiratory 
tract infections (84), or to a tailored intervention to reduce inappropriate prescriptions 
for elderly patients (85). The groups served as control for each other. Throughout this 
thesis, when describing the Rx-PAD study, I refer to the half of the study using the 
RTI-arm as intervention group and the prescriptions for elderly-arm as control group. 
(ClinicalTrials.gov: NCT00272155) 
 
Outcome measures 
Primary outcome measures were changes in antibiotics prescription rates and in 
broad- vs narrow-spectrum antibiotics rates in patients with RTI after the tailored 
educational intervention. 
 
Participants and randomisation 
In Norway, specialists in general practice must apply for renewal of their specialist 
status every five years. In this renewal process, participation in a CME group is 
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compulsory. All peer groups (n= 250) on average consisting of seven to eight 
colleagues located in 11 counties in the southern part of Norway, were invited to 
participate in the trial. Full participation in the project was rewarded with meriting 
points for a so called "clinical topic course" necessary for the renewal of the specialty 
status. GPs using one of four major electronic medical record (EMR) systems 
(Infodoc®, WinMed®, ProfDoc Vision® or System X®) were eligible for the trial. Of 
the 98% of Norwegian GP’s offices that use EMR systems, 95% use one of these four 
systems (86).  
Of the 250 invited groups, 81 accepted. 37 groups did not respond to the 
invitation, while the remaining 132 groups did not want to participate. The 
participating 81 groups were randomised to either the intervention or control group 
through a manual randomisation strategy based on drawing lots, performed by a 
person not involved in the study. 40 CME groups were randomised to the 
intervention group. Before the start of the intervention, one of these CME groups was 
closed down, resulting in 39 CME groups with 207 GPs in the intervention arm, and 
41 CME groups with 243 GPs in the control arm. 382 GPs (intervention/control) 
delivered data for both baseline and intervention periods. 
 
Intervention 
We developed an intervention through a process of identifying inappropriate 
prescriptions of antibiotics for RTIs. Identification of irrational antibiotic treatment 
was based on a guideline on antibiotic prescriptions issued by The Norwegian Board 
of Health 2000 (87). This guideline was distributed to all Norwegian GPs in 2000 and 
was also available on the Internet. Examples of suboptimal antibiotic prescribing 
according to this guideline are listed in Table 1.  
We recruited 13 GPs to tutor the intervention, each responsible for three CME-
groups. The tutors, named Prescription Peer Academic Detailer (Rx-PAD) were 
recruited on basis of affiliation to the Department of General Practice, University of 
Oslo, and/or a known interest in RTIs in primary care. The Rx-PADs received a four 
days pre-study training program, focusing on the evidence of antibiotic treatment of 
RTI, pedagogical techniques, and how to install and use the software program for data 
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extraction. 
The tailored intervention towards the GPs in the CME groups included two 
educational outreach visits, each lasting two to three hours, performed by the groups 
responsible Rx-PAD. In addition, there was a one-day regional seminar gathering 10-
15 CME groups. 
 
Table 1: Examples of inappropriate antibiotic prescription patterns according 
to guidelines by The Norwegian Board of Health 2000 
x Uncomplicated acute otitis media (AOM) in children > 1 year of age with 
symptoms < 3 days 
x Acute sinusitis with moderate symptoms < 7 days 
x Acute tonsillitis without positive indication of infection caused by group A 
Streptococcus 
x Acute bronchitis (except verified infections caused by Mycoplasma pneumonia 
or Chlamydia pneumonia) 
x Use of broad spectrum antibiotics where penicillin V could be prescribed 
 
In the first outreach visit, the main elements of the intervention were presented, 
with special emphasis on evidence-based prescribing of antibiotics for RTIs in primary 
care, choice of first-line drugs, and treatment goals. The participants were encouraged 
to discuss the advices given. During the visit, a software package was delivered each 
participant, to be installed on their practice computer. The software extracted data 
from the preceding 12-month period (01.12.2004 – 30.11.2005) and saved them on a 
floppy disk, which was to be sent to the study administration. These data were used to 
generate feedback reports, and comprise the baseline data of this study.  
Prior to the second outreach visit, the participants received a personal feedback 
report, comprising the GPs number of consultations for the various RTI diagnoses, 
antibiotics prescribing rates, broad-spectrum antibiotics precribing rates, and average 
numbers/rates for both the CME group and the whole Rx-PAD study.  
The second outreach visit took place about two months after the first visit, and 
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focused on the newly revealed prescription patterns. The Rx-PAD facilitated the 
discussion within the peer groups, based on individual feedback reports, enabling 
participants to compare their prescription patterns with the other participants and the 
overall averages. The discussion aimed at critical reflection towards their own 
prescription strategies for RTIs and the disclosure of areas where individual 
improvements were desirable and possible.  
Around two months after the second outreach visit, all participants were 
gathered in regional work-shops where evidence-based rationale behind 
pharmacological treatment of RTIs in primary care were outlined in more depth on 
the basis of baseline prescription data. Fifteen months after the first data extraction 
period ended, a second data extraction of the GPs' prescribings for the preceding 12-
months period (01.03.2006 – 28.02.2007) were undertaken. These data comprise the 
intervention data of this study.  
 
Data handling  
Data extraction software was developed for this study. The dataset from each 
individual GP provided information on number of patient encounters, diagnosis 
linked to each encounter for patients with a RTI diagnosis, and antibiotics prescription 
details linked to each encounter for patients with a RTI diagnosis. Diagnosis was 
based on the International Classification of Primary Care (ICPC-2), and prescription 
details were based on the Anatomical Therapeutic Chemical (ATC) Classification 
System with Defined Daily Doses (DDDs). 
Because the data did not permit to separate initial encounters from follow-ups, 
all encounters with an identical ICPC-2 code for an individual patient within a four 
week period was treated as one RTI episode. 
During data analysis, we chose to group ICPC-2 codes reflecting similar illnesses 
together: upper RTIs (URTIs) and respiratory symptoms (R01–05, 07–29, 74 and 80); 
ear infections (H01, 71, 72 and 74); and other RTIs (R71, 77, 82 and 83). Other 
included RTI diagnoses were acute tonsillitis (R72 and 76), sinusitis (R75), acute 
bronchitis (R78) and pneumonia (R81). 
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Sample size 
Based on previous studies, we anticipated an antibiotics prescribing rate for RTIs of 
27% (88) and an intra-cluster correlation coefficient of 0,085 (89). We expected an 
average of seven GPs per CME group, and 300 encounters for RTIs per GP during 
the intervention period. A reduction in antibiotics prescribing rate for RTIs of one 
third was considered clinically relevant. Given these figures and applying an 80% 
power and a 5% significance level, we found an intervention sample size requirement 
of 31 CME groups and a corresponding number of control groups. 
  
Ethics and data security  
The participating GPs gave their written informed consent. In order to use patient 
identification data, The Directorate for Health and Social Affairs approved 
dispensation from the health-professional secrecy. Approval from The Norwegian 
Social Science Data Services (NSD) was obtained, which implied acceptance to extract 
prescription data. The Regional Committee for Research Ethics in Oslo, Norway, 
approved the study (S-05272).  
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Paper I – The intervention study 
Design 
Cluster-randomised controlled trial with an embedded controlled trial. 
   
Main outcome measure 
Dispensed antibiotic prescriptions as a proportion of prescribed antibiotic 
prescriptions. 
 
Interventions and randomisation 
The cluster-randomised controlled trial – educational intervention 
A recommendation of delayed antibiotic prescribing was included in the educational 
intervention of the Rx-PAD study. At the first outreach visit, the Rx-PADs presented 
results from RCTs on delayed prescribing, and encouraged a discussion on the topic. 
At the regional work-shops, I held a 30-minute lecture on delayed prescribing, and 
presented the strategy as a possible tool to decrease the patients use of antibiotics.  
 
The embedded controlled trial – pop-up-reminder intervention 
In the educational intervention group, a subordinate trial was embedded. For two of 
the four eligible EMR systems (WinMed® and ProfDoc Vision®), the software 
package included a pop-up window to appear on the computer screen when 
antibiotics were prescribed, expect from antibiotics merely used for conditions other 
than RTIs (nitrofurantoin, pivmecillinam, trimetoprim). The window contained a 
question on whether the prescription was a regular or a delayed prescription 
(Appendix E). 
The Rx-PAD study protocol (84) describes the pop-up software merely as a tool 
to identify delayed prescriptions. However, during the further planning of the study 
and before the intervention took place, it became evident to us that the pop-up might 
have an effect on the delayed prescribing rate and thereby on the dispensing rate.  
GPs with the two other EMR systems (Infodoc® and System X®) served as 
control for the pop-up intervention group. As such, there was no randomisation in 
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this trial. This was chosen out of convenience, as the development of software for 
each EMR system was resource-intensive. Among Norwegian GP’s offices using one 
of the four EMR systems, approximately 76% use WinMed® or ProfDoc Vision®, 
while 24% use Infodoc® or System X® (86). In the Rx-PAD intervention group, 69% 
of the GPs (107/156) had the pop-up-reminder software installed, while 31% 
(49/156) did not have the reminder.  
There were no statistically significant differences between the pop-up 
intervention group and its control regarding GP’s gender, age, speciality status, 
practice location, practice type, antibiotic prescription rate at baseline or number of 
patient encounters. At baseline, the intervention group GPs had more female patients 
(59,6% vs 56,8%), more patients with uppert RTI/RTI symptoms (25,7% vs 23,3%), 
pneumonia (11% vs 9,7%) and other RTIs (5,6% vs 3,5%) and fewer patients with 
tonsilitis (14,1% vs 16%) and lower RTIs (15,3% vs 17,8%) than the control GPs. 
There were no significant differences between the two groups regarding the consulting 
patients’ age.  
 
Data handling  
The prescription data used in this study equals the EMR system data described in the 
Rx-PAD study section. In addition, for the pop-up-reminder intervention group, the 
software package extracted data on whether a prescription was to be filled 
immediately, or whether it was a delayed prescription, and for how long the patient 
should wait before deciding to use the antibiotics. 
In order to register whether a prescription was picked up at a pharmacy, data 
from the EMR systems were merged with data provided by the Norwegian 
Prescription Database (NorPD). NorPD is a national registry including data for all 
prescription drugs issued at Norwegian pharmacies, established in 2004 (90). The 
merging was based upon the prescribed antibiotics’ ATC code, the patient’s Birth 
Number (the unique identification numbers for Norwegian citizens), the GP’s unique 
Health Personnel Register Number, and dispense date within 21 days after 
prescription date. 
As the main outcome measure in this study was prescription pick-up rate and 
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not prescribing rate, our level of observation was patient encounters resulting in an 
antibiotics prescription, as opposed to RTI episode with or without antibiotics prescribing used in 
the rest of the Rx-PAD study. 
 
Participants 
382 GPs delivered floppy disks with extracted prescription data from both the 
baseline and intervention periods (88790 prescriptions). Of these, 33 GPs were 
excluded because they did not get data in return from NorPD due to late delivery of 
floppy disks to the project administration (29 GPs), or because none of the patients’ 
Birth Numbers were registered in their EMR system (4 GPs). 14 GPs in the 
educational intervention control group were excluded because they – by a mistake – 
were equipped with the pop up reminder-software (12 GPs) or because they got 
NorPD data only for patients > 70 years (2 GPs).  
1633 prescriptions were excluded because the corresponding patients were not 
registered with a Birth Number in the GPs EMR system, hence, these prescriptions 
could not be merged with NorPD data. Also, 3045 prescriptions were excluded 
because the ATC number was not properly registered in the GPs EMR system, which 
impeded both the pop-up software function and the merging with the NorPD data. 
After the establishment of the NorPD register 01.01.2004, the Norwegian GPs 
were required to fill in their Health Personnel Number and the patients’ complete 
Birth Number on the prescription. At the start year of the RxPAD study, 3.7% of all 
dispensed medications registered in the NorPD lacked Birth Number, while the 
corresponding proportion at the end of the study was 1.9% (Personal communication, 
NorPD 20110812). This would account for an artefact increase in pick up rate from 
baseline period to intervention period for some of the GPs.  
Most of the prescriptions lacking Birth Number in this study were excluded on 
basis of lacking number in the GPs EMR system. However, included prescriptions 
may have been printed out without Birth Number.  
Five GPs in our material had an increase in pick up rate > 30 percentage points 
from baseline to intervention period, while the GP with the largest decline had a 17 
percentage points decrease. We assume that this is an artefact due to the decrease in 
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missing Birth Numbers from baseline to intervention period registered at the NorPD. 
In order to compensate for this error, we chose to exclude the five outlying GPs with 
the highest pick-up rate increase. 
The figure in Appendix A displays the participating GPs in relation to the GPs 
participating in the other two studies. 
 
Statistics 
Two logistic regression analysis were performed with the dependent variable being 
whether the prescription was picked up at a pharmacy or not, and whether the GP 
issued the prescription as a wait-and-see-prescription or not.  
We included random intercepts at two levels: GP and CME group. A model 
including random slopes at the GP level (i.e. allowing patient variables age, gender and 
diagnoses to vary amongst GPs) did not fit the data due to numerical overflow. The 
included random effects were statistically significant. 
Adjusted odds ratios can not approximate the risk ratios when the incidence of 
the outcome of interest is common (>10%) (91). As our outcome – prescriptions 
being dispensed – is very common, we approximated the risk ratios from the odds 
ratios using a standard correction method (91). 
A significance level of 5% was applied. The descriptive analyses were performed 
using PASW Statistics 18 (www.spss.com), while the multilevel regression analyses 
were performed using STATA 11.2 (www.stata.com). 
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Paper II – The focus group study 
Participants 
The data in this study were generated in five focus group interviews with GPs 
participating in the antibiotic arm of the Rx-PAD Study. One of the groups was a 
purpose-constructed group assembled at a general practitioner congress, while the 
other four groups were existing CME groups.  
The CME groups and the individual GPs in the purpose-constructed group were 
recruited using a purposeful sampling strategy, aiming for variety in the sample with 
respect to geography, age, gender, and antibiotic prescribing rates. Also, we sought for 
homogenity in the groups with respect to gender (92). One of the groups consisted of 
only women, one group of only men, while the other three groups were mixed.  
The CME group secretaries and the participants in the purpose-constructed 
group were approached first by e-mail, then by telephone as a follow-up of the e-mail. 
The sample size of five focus groups was a result of the strategic sampling of a 
minimum of one pilot group (which also was a male only group), one female CME 
group, two mixed CME groups from different geographical areas, and one non-CME 
group. When these groups interviews were conducted, we experienced saturation in 
the data, as the latest interviews yielded little new information. As a result, we stopped 
the recruitment. 
The focus groups consisted of from three to eight members, with a total of 33 
participants. There were 15 female GPs, and the mean age was 50 years. Table 1 in 
paper II presents the characteristics of the participants. 
The participants were granted anonymity. As no patients were involved in this 
study, we did not apply for ethical approval by The Regional Committee for Research 
Ethics. 
The figure in Appendix A displays the participating GPs in relation to the GPs 
participating in the other two studies. 
 
Interviewer’s role, background and perspectives 
I brought some important preconceptions and beliefs with me into this study. On 
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basis of several RCTs on delayed prescribing showing the strategy’s ability to decrease 
antibiotics consumption, delayed prescribing was set to be an integrated part of the 
educational intervention in the Rx-PAD study. Being a part of the Rx-PAD research 
team, I shared the view that there is an overprescribing and overuse of antibiotics for 
RTIs in Norway, and that advocating delayed prescribing among GPs might decrease 
this overuse. Being aware of the relatively low antibiotics prescribing in Norway (9), I 
expected that Norwegian GPs were concerned with prudent antibiotics prescribing 
and would welcome a strategy that could decrease the use even further, but also that 
the GPs might be content with the relatively low antibiotics use. I assumed that the 
participants would have divergent views on strategy, and that proponents of prudent 
prescribing and patient-centeredness would be most positive.  
I presented myself in the focus groups as a general practitioner and PhD-student 
working with a project on delayed prescribing within the Rx-PAD study. Most of the 
participants had already met me at the Rx-PAD study regional work-shop, and heard 
me recommend delayed prescribing as a potentially effective strategy to lower 
unnecessary antibiotics use. Consequently, the participants might have expected that I 
wanted to hear positive statements on the strategy. Hence, I underlined that I was 
especially interested in negative experiences, side effects and limitations of delayed 
prescribing.  
 
Interviews 
We developed an interview guide with open-ended and wide-ranging questions, 
covering experiences and views of the GPs on delayed prescribing (Appendix B). The 
group interviews were conducted between October 2006 and September 2007. We 
considered focus group interviews as an appropriate method to highlight views and 
divergent opinions (93). I acted as moderator for four focus group interviews while 
the co-supervisor was moderator for one interview. The co-supervisor was also 
present as an observer at two of the interviews I moderated.  
The first group served as a pilot, and the interview guide was slightly moderated 
after the pilot interview. Each of the focus group interviews lasted for 45–75 minutes, 
and took place where the CME groups usually held their meetings. GPs were 
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encouraged to share their views in an open discussion, and the moderator ensured that 
all participants were heard. The discussions were audio-recorded digitally. Preliminary 
findings from the first interviews were fed back into later focus groups for further 
discussion. The pilot interview was analyzed together with the other four interviews. 
 
Analysis 
Audio-recordings were transcribed verbatim. The material was analysed using a 
procedure for content analysis referred to as “systematic text condensations”, inspired 
by Giorgi (94) and modified by Malterud (95). The procedure comprise the following 
four steps: (i) reading all the material to obtain an overall impression, actively 
bracketing previous ideas and preconceptions, and identifying main themes in the 
material; (ii) identifying units of meaning, representing different aspects of GPs’ 
experiences with delayed prescribing within each main theme, and coding for these; 
(iii) condensing and summarising the contents of each of the coded groups; and (iv) 
generalising descriptions and concepts about specific themes. All the authors took part 
in the analysis, and met to discuss the meaning of the data and the interpretation of 
the material. NVivo7 software (www.qsrinternational.com/products_nvivo.aspx) was 
used for coding. Quotes from interviews were translated from Norwegian into English 
by the authors. 
Some of the items from the interview guide were brought in as main themes in 
step (i), while the other main themes emerged from the material. In the analysis, we 
sought to focus at the GPs hands-on experience and views on the delayed prescribing 
strategy in a clinical setting. Thereby, we left out a small number of main themes after 
step (ii), notably themes concerning the pop-up-reminder software and the concept of 
power in the doctor-patient relationship. 
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Paper III – The questionnaire study 
Subjects and setting 
We translated and adopted a questionnaire on patients’ response to delayed 
prescription used in a previous study (32) (Appendix D), and developed a 
corresponding GPs’ questionnaire comprising questions on background information 
(patients age, gender), diagnosis, reason for issuing wait-and-see prescription, 
reasonableness of the strategy, and the GPs assumption on patient satisfaction, patient 
demand for antibiotics and whether the patient was going to use the prescription 
(Appendix C). The GP questionnaire was piloted.  
As part of the one-day seminar described in the Rx-PAD study section, I gave a 
30 minute lecture on the evidence regarding delayed prescribing, and invited the GPs 
to participate in, and recruit patients to, a questionnaire survey. Of the approximately 
150 GPs who attended the seminar, 58 GPs agreed to participate. In addition, 16 GPs 
affiliated to the Department of General Practice, University of Oslo, were given the 
same lecture, and agreed to participate (Figure 1).  
Eligible patients were those of any age who consulted the GP for a RTI, and to 
whom the GP found it appropriate to offer a wait-and-see prescription. In the course 
of the consultation, the GP handed the patient an antibiotic prescription together with 
a patient questionnaire, an information leaflet with a consent form, and a prestamped 
envelope. The patient was instructed to wait for a certain amount of time, chosen by 
the GP, before deciding whether to take the antibiotics or not. Apart from this, we did 
not standardise the way of practicing the delayed prescribing strategy, as to what 
advice the GP was to give the patient, selection criteria etc. The information leaflet 
ensured that the patients received a minimum of identical information.  
The patient questionnaire was to be filled once the patient had made the decision 
whether to use the antibiotics or not. After the consultation, the doctor filled the GP 
questionnaire. Patients were rewarded with a scratch card upon responding, while the 
GP would receive a gift card for a CD when they had recruited 10 patients. 
Recruitment took place during April 2006 through June 2008. The Regional 
Committee for Research Ethics in Oslo, Norway, approved the study (S-05272). 
The figure in Appendix A displays the participating GPs in relation to the GPs 
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participating in the other two studies. 
 
Statistical analysis 
Chi square test was used to compare those patients who reported to consume 
antibiotics and those who did not, with regard to both patient factors (demographic 
characteristics, presenting symptoms, expectations, confidence in deciding whether to 
use the prescription) and GP factors (diagnose, reason for giving wait-and-see 
prescription, reasonableness, and impression of expectations and use of the 
prescription). Logistic regression analysis was performed with the dependent variable 
being whether the patient reported to consume the antibiotics or not. Further, we 
compared cases where the GP found delayed prescribing very reasonable and cases 
where where the GP did not. A significance level of 5% was applied. Analyses were 
performed using SPSS 14 and 18. 
 
Material 
Out of a total of 68 GPs, 49 (72%) recruited on average 8.5 patients each (median 6; 
span 1-34). 19 (28%) GPs recruited no patients. We received 413 responses from GPs 
and 332 responses from patients. Five patients informed that they did not want to 
participate, and consequently we removed the corresponding GPs responses. For five 
of the patient responses, we did not receive a corresponding GPs response, resulting 
in 327 response pairs and a patient response rate of 80%. 17 response pairs were 
excluded because the GPs had included patients who were treated for other conditions 
than RTIs, and an additional six response pairs were excluded because the patients 
failed to answer whether they had taken antibiotics. 304 response pairs remained for 
analysis. We grouped diagnoses according to previous studies on RTIs (18, 25), 
described in the Rx-PAD methodology section of this thesis, with the exception that 
R80 Influenza was categorised as “Other respiratory diagnoses” and that R78 Acute 
bronchitis and R81 Pneumonia was grouped together in one category; “Lower RTIs”.  
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Summary of results 
Paper I – The intervention study 
Høye S, Gjelstad S, Lindbæk M. 
Effects of interventions to promote delayed prescribing for respiratory tract 
infections on antibiotic-dispensing rates.  
Provisionally accepted, Br J Gen Pract. 
 
The aim of this paper was to measure the effects of a GP educational intervention and 
a computer delayed-prescribing pop-up reminder on antibiotic-dispensing rates. 
Secondary aim: to identify factors influencing GPs’ decisions to issue delayed 
prescriptions for RTIs and patients’ decisions to fill their prescriptions. 
At baseline, 92% of antibiotic prescriptions were filled at pharmacies. An 
educational intervention on prudent antibiotic prescribing including a 
recommendation of delayed prescribing, combined with a pop-up reminder on delayed 
prescribing, resulted in a 3% reduction in approximated risk (RR 0.97, 95% CI 0.95 to 
0.99) of prescribed antibiotics being dispensed, without any increase in antibiotic 
prescribing rate. The educational intervention alone produced a 1% reduction in 
approximated risk (RR 0.99, 95% CI 0.97 to 1.01) of antibiotics being dispensed. 
Delayed prescriptions were filled in 59% of all cases. 
Having pneumonia or acute tonsillitis and being of older age increased the odds 
of the prescription being filled at a pharmacy. Patients with acute sinusitis, otitis 
media, or upper RTI and symptoms and patients of younger age had the highest odds 
of receiving a delayed prescription. 
We conclude that promoting delayed prescribing through lectures and group 
visits alone is insufficient to influence medication-dispensing rates. However, a 
constant reminder of the delayed-prescribing option through a computerised pop-up 
reminder results in a small, though statistically significant decrease in the number of 
filled prescriptions. This strategy for decreasing antibiotic consumption is most 
effective in children and in adults with otitis, sinusitis, or upper RTIs. 
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Paper II – The focus group study 
Høye S, Frich JC, Lindbæk M.  
Delayed prescribing for upper respiratory tract infections: a qualitative study of 
GPs' views and experiences.  
Br J Gen Pract. 2010; 60: 907-12. 
 
The aim of this paper was to explore GPs’ views on and experiences with delayed 
prescribing in patients with acute upper respiratory tract infections. 
We found that GPs viewed delayed prescribing as a method that was well suited 
to the spirit of clinical work in general practice, although their views differed on the 
usefulness of the strategy. GPs who endorsed delayed prescribing emphasised shared 
decision making and the opportunity to educate the patient. GPs who were negative 
said that they mainly used the strategy in what they experienced as an uncomfortable 
situation of being forced to prescribe. 
Mild and mainly harmless conditions that might be of bacterial origin, such as 
acute sinusitis and acute otitis, were considered most suitable for delayed prescribing, 
as opposed to conditions that were considered as purely viral, such as common cold. 
An important argument for issuing a wait-and-see prescription was to help the patient 
to avoid seeking after-hours care, especially during holidays and weekends. 
For issuing a wait-and-see prescription, the GPs required that the patient was 
‘knowledgeable’, able to understand the indications for antibiotics, and motivated for 
shared decision making. GPs emphasised the importance of informing the patient 
thoroughly when issuing a wait-and-see prescription. 
We conclude that delayed prescribing is not endorsed by all GPs, but the strategy 
appears to be a feasible approach among informed patients with early symptoms of 
mild URTIs of a possible bacterial origin, such as acute otitis and acute sinusitis. 
Informing the patients properly while issuing wait-and-see prescriptions is essential. 
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Paper III – The questionnaire study 
Høye S, Frich JC, Lindbæk M.  
Use and feasibility of delayed prescribing for respiratory tract infections: A 
questionnaire survey.  
BMC Fam Pract 2011; 12: 34. 
 
The aim of this paper was to explore GPs use and patients uptake of wait-and-see 
prescriptions for RTIs, and to investigate the feasibility of the strategy from GPs’ and 
patients’ perspectives. 
General practitioners who have been informed about the use of wait-and-see 
prescriptions in RTIs, most often use the strategy in cases of acute sinusitis and acute 
otitis media. These are also the diagnoses for which the GPs find the strategy most 
reasonable. The reported reason for issuing a wait-and-see prescription is most 
commonly uncertainty about indication for antibiotics. Patients receiving a wait-and-
see prescription are confident in the decision whether to start taking the medication, 
and half of the patients report to consume the antibiotics. Feeling very ill, having 
fever, and being more than 16 years of age predict consumption of antibiotics, while 
reporting nasal congestion is negatively associated with consuming antibiotics. 
We conclude that most patients and GPs are satisfied with the delayed 
prescribing strategy. The patients’ age, symptoms and malaise are more important than 
the diagnosis in predicting antibiotic consumption. The GP’s view of the method as a 
reasonable approach depends on the patient’s diagnosis. In our setting, delayed 
prescribing seems to be a feasible strategy, especially in cases of sinusitis and otitis. 
Educational efforts to promote delayed prescribing in similar settings should focus on 
these diagnoses. 
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Discussion 
Methodological considerations 
Overall methodological discussion 
This thesis is concerned with the GPs; their attitudes, experiences, and prescribing 
behaviour. We did not set out to measure the clinical effect of delayed prescribing, as 
this is well documented in RCTs. Patients have contributed with symptom description 
and reported antibiotics consumption in the questionnaire survey, and with actual 
prescription filling data in the intervention study. However, the patient level mainly 
serves as a tool to measure how the GPs’ behaviour affects antibiotics dispensing.  
 
Sampling / External validity 
The participants in all the three studies – except for a small number of GPs taking part 
in the questionnaire study – were members of CME groups who through their group 
coordinator had agreed to participate in a quality improvement study; the RxPAD 
study. We do not know if the groups practiced a democratic decision on whether to 
participate, in which a minority of the members might have objected but still were 
obliged to participate, or whether the decision to participate had to be unanimous 
among the group members. Still, one may argue that the 328 participants, constituting 
80 CME groups, might hold more positive views towards quality improvement 
projects and be more ready to change prescribing patterns compared to the 169 
groups who rejected or did not answer the invitation. This may challenge the 
generalisability of our results. Therefore, we did calculations to compare the 
participants with the non-participants. As readiness to change or attitudes towards 
delayed prescribing was not measured among non-participants, our best measurement 
was antibiotics prescription details. This is by no means a perfect measurement, but 
there is reason to believe that GPs interested in antibiotics stewardship also prescribe 
less antibiotics and a higher rate of narrow-spectrum antibiotics. We have no data on 
numbers of RTI encounters by non-Rx PAD GPs, thereby we can not calculate 
prescribing rates. However, the NorPD database offers total numbers of antibiotics 
prescriptions and the narrow-spectrum/broad-spectrum antibiotics rates for all 
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Norwegian specialists in general practice, and these data show no significant 
differences between RxPAD participants and no-participants (20).  
One may also argue that the participants in the focus group and questionnaire 
studies were additionally positive towards methods that aim to lower the use of 
antibiotics in general, and delayed prescribing in particular, as they had agreed to take 
part in studies on delayed prescribing. However, in the focus group study, both GPs 
with high and low antibiotic prescribing rates were included, and both positive and 
negative views towards the strategy were exposed. In the questionnaire study, we did 
not record the participants antibiotic prescribing rates. A substantial proportion of the 
participants (39%) recruited only 1-4 patients, indicating that they seldom used delayed 
prescribing. The results from the questionnaire study are understandably generalisable 
only to GPs who are sufficiently positive towards delayed prescribing that they actually 
use the strategy to a greater or lesser degree. 
As participants in the RxPAD study, most of the focus group and questionnaire 
study participants had attended the one-day seminar where I recommended delayed 
prescribing as a strategy to lower unnecessary antibiotics use. I tried not to 
recommend delayed prescribing for certain patient groups, diagnoses or situations. 
Still, my lecture may have influenced on the GPs views and behaviour. 
 
Triangulation  
The term method triangulation, often used in qualitative research, refers to using more 
than one method when studying a phenomenon (96). Triangulation may reduce the 
risk of bias and enhance the validity of qualitative research. This thesis builds on 
method triangulation, as three different methods are used to explore delayed 
prescribing.  
All the focus group participants and most of the questionnaire survey 
participants also participated in the Rx-PAD study. This might be seen as a weakness, 
as described in the previous section, but also as a strength, as the coherence between 
the three studies shows that the GPs actual use of delayed prescribing corresponds to 
what they tell they do in the focus group and questionnaire studies. As such, the 
intervention study validates the findings in the focus group and questionnaire studies. 
46 
 
All the three studies in this thesis were carried out simultaneously, for practical 
and logistic reasons. A better approach would have been to conduct the focus group 
study prior to the two other studies. In the questionnaire study, when asked why they 
issued a delayed prescription, the large majority of the GPs chose the option 
“Uncertainty about indication for antibiotics” (69% of the cases), and the option 
”Other reasons” was chosen in as many as 14% of the cases. Based on the results 
from the focus group study, more relevant options such as “Short duration of 
symptoms” and “Patient convenience” might have yielded more accurate results. Also, 
in the intervention study, results from the qualitative study could have been presented 
at the group meetings, facilitating an open discussion on potential reluctance towards 
delayed prescribing.  
 
Diagnosis grouping 
In our studies, we chose to group ICPC-2 codes reflecting similar illnesses together, in 
the same manner as earlier research done by the same research members. The most 
questionable factor of this grouping was to put all the symptom diagnoses in the 
category Upper RTI, as some symptom diagnoses might be closer related to other 
categories. The obvious examples of this are R05 Cough (might belong to category 
Lower RTI), R09 Sinus symptom/complaint (might belong to the category Sinusitis), 
and R21 Throat symptom/complaint (might belong to the category Tonsillitis).  
In the questionnaire survey, 17 (28%) of the 60 prescriptions in the Upper RTI 
category where symptom diagnoses. In the intervention study, of the 17616 
prescriptions in the Upper RTI category, 8310 (47%) were symptom diagnoses, of 
which 4710 were R05 Cough, 494 were R09 Sinus symptom/complaint and 2134 were 
R21 Throat symptom/complaint. The results in both studies would have been 
different if we choose other ways of grouping the diagnosis. However, we have to 
assume that the GPs, when diagnosing the patient, chose symptom diagnoses when 
the illness did not meet the criteria of a certain disease, and that including e.g. R09 
Sinus symptom/complaint in the Sinusitis category would distort the results from this 
category. An alternative solution would be to include a Symptom diagnoses category, 
but we wanted to keep the number of categories as low as possible. The result is that 
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the category Upper RTI and RTI symptoms is a heterogenic group of diagnoses, and 
this must be taken into account when comparing our results with other research. 
 
The diagnostic problem 
Most quality improvement studies and randomised, controlled trials on RTIs in 
primary care are diagnosis specific, ie they deal with one specific respiratory tract 
infection, with detailed inclusion and exclusion criteria (22-24, 97). In our studies, 
patients with all kinds of RTIs were included, and the registered diagnoses were based 
purely upon the individual GPs assessment, without any explicit diagnostic criteria. 
There are several problems connected to this approach. The diagnostic assessment 
and accuracy may vary greatly from GP to GP – what one GP diagnoses as acute 
sinusitis, another GP may diagnose as sinus symptoms, or use the broader category of 
upper respiratory tract infection (even though the latter diagnosis, according to ICPC-
2, exclude acute sinusitis). The inter-rater reliability of the ICPC-2 is found to be only 
fair to moderate on the single code level (98).  
Also, it is documented that GPs may chose a treatment option prior to choosing 
diagnosis, and thus be in danger of choosing a diagnosis that “fits” with the treatment 
given (99, 100). In addition, for using some of the functions in the EMR systems (e.g. 
printing a sickness certificate), one has to specify a diagnosis. If one needs to use any 
of these functions early in the consultation, one may choose a “preliminary” diagnosis 
prior to anamnesis and examination, without correcting the diagnosis if the anamnesis 
or examination proves it wrong.  
Finally, participating in a educational study on appropriate antibiotics prescribing 
and receiving a personal prescribing patterns report, may have altered the diagnostic 
process, so that diagnosing may vary from baseline to intervention period. For 
example, our message that the diagnosis of acute bronchitis does not warrant 
antibiotics may have caused GPs to rather diagnose a lower RTI as a pneumonia if the 
GP chooses to treat the condition with antibiotics. This possible shift in diagnosing is 
an unintended, but probable effect of the intervention, and is yet to be explored.  
The use of the diagnosis R83 Respiratory infection other demonstrates some of the 
problems mentioned above. According to the full version of the ICPC-2, the diagnosis 
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includes “chronic nasopharyngitis; chronic pharyngitis; chronic rhinitis not otherwise 
specified; diphtheria; empyema; epiglottitis; fungal respiratory infection; lung abscess; 
protozoal infection (without pneumonia)” (101). These conditions are either very rare 
in primary care, or they are not primarily bacterial infections. Still, in the intervention 
study, R83 Respiratory infection other constitutes 4182 (5,8%) of the 72512 prescriptions, 
making up 89% of the 4680 prescriptions in the “Other RTIs” category. In the 
questionnaire survey, the same diagnosis constitutes two (0,7%) of the 304 wait-and-
see-prescriptions, making up 15% of the 13 prescriptions in “Other RTIs” category. 
The Norwegian main title of R83 is “Luftveisinfeksjon IKA”, directly translated 
“Respiratory tract infection NOS” (Not Otherwise Specified). The reason for this 
most probable overuse of the R83 diagnosis in the intervention study may be lack of 
knowledge on the diagnostic criteria, use of “preliminary diagnosis”, diagnostic 
uncertainty and lack of time. In the questionnaire survey, the GPs were to fill the 
diagnosis onto the questionnaire sheet, and this may have given better time for an 
accurate diagnosis.  
All in all, we chose to include all RTIs and to let the GPs use their own 
diagnostic criteria, both to get an overall picture of delayed prescribing for RTIs, to 
mimic the everyday practice, and because the study would be impossible to implement 
in such a large scale if the GPs were to adhere to explicit diagnostic criteria.  
 
Paper I – The intervention study 
There was a relatively large exclusion rate in this study; from the 382 GPs delivering 
data on 88790 prescriptions from both baseline and intervention period to the 
included 328 GPs (14,1% excluded) with 72512 prescriptions (18,3% excluded). This 
is largely caused by late delivery of data from some of the GPs, erroneous software 
installation, and lacking information preventing the merging of the EMR and the 
NorPD dataset. There were significantly more female GPs (34% vs. 22%) and 
specialist GPs (89% vs. 80%) among the included GPs. On all other GP 
characteristics, including antibiotic prescription rate, there were no significant 
differences between included and excluded GPs.  
The main outcome variable; dispensing rate, is based on achieved data in relation 
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to non-achieved data; when NorPD data is lacking on one specific prescription, we 
assume that that prescription has not been dispensed at any pharmacy. However, 
lacking data may have other causes; missing or wrong information on the prescription, 
missing or wrong registration at the pharmacies, and failures in the data flow between 
the databases. We have actively and intensively sought for such errors, and eliminated 
the ones we have found. Still, there might be hidden errors resulting in a falsely low 
dispensing rate. However, the baseline dispensing rate of 92% is in accordance with 
the levels found in other studies. Also, the different dispensing rates we have observed 
in the intervention and control groups would be equally influenced by any falsely low 
dispensing rate. 
The pop-up reminder and -registration software did not pop up for every 
prescription issued by the pop-up intervention GPs; the GPs issued 12.435 
prescriptions in the intervention period, while the software registered 10.860 (87%) of 
these prescriptions as either delayed og regular. This may be due to change of 
hardware during the intervention period, or that some of the GPs may have 
uninstalled the software or printed out prescriptions from other computers than their 
own. We used the intention to treat-principle, hence all prescriptions issued by GPs 
who got the pop-up software installed, were analysed as belonging to the pop-up 
intervention group. 
When a prescription is not picked up at a pharmacy, this is not necessarily an 
indication that the corresponding patient has taken an active choice not to use the 
antibiotics. Ekedahl and Månsson interviewed Swedish patients not claiming their 
electronically transmitted prescriptions (102). 17 of the examined prescriptions were 
for antibiotics, and for 9 of these, the reason for not claiming it was exclusively related 
to the electronic transmission. For the remaining eight prescriptions, half of them 
were delayed / “as-needed” prescriptions, while the other four remained unclaimed 
because the patient had another prescription for the same medication/ had leftovers 
/got a double set of prescriptions (Personal communication, A. Ekedahl). In spite of 
very low numbers, the findings illustrate that unfilled antibiotics are not equivalent to 
delayed prescriptions, or to a situation in which the patient is rid of the disease. This 
must be taken into account when considering our results.  
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We have used the primary non-adherence, ie the proportion of prescribed 
antibiotics not dispensed at pharmacies, as our outcome measure. In our analyses, we 
have not separated between dispensed delayed prescriptions and dispensed regular or 
uncategorised prescriptions. This raises the question of whether primary non-
adherence of antibiotics for RTIs in primary care is a wanted or unwanted 
phenomenon. In the research literature, undispensed delayed prescriptions are 
obviously wanted, while non-adherence is said to contribute to worsening of disease 
and increased health care costs (103), and in the case of RTIs, to waste health 
resources, to possibly impact on health outcomes, and to result in leftover antibiotics 
that can be used as self-medication with the risk of increasing the pressure for 
antibiotic resistance (104), ie an unwanted phenomenon.  
As there was no clinical monitoring of the patients in our studies, we have no 
account of the clinical outcome for patients who did or did not fill their antibiotics 
prescription. However, as seen in RCTs on delayed prescribing, there are only 
marginal differences in clincal outcome for patients receiving immediate, delayed or no 
antibiotics (43). Also, Francis et al found no differences in clinical outcomes between 
fully adherent and not adherent patients prescribed antibiotics for acute cough (104). 
As such, an increase in unfilled prescriptions as a result of the intervention should not 
be of clinical concern. 
The pick-up rate is a proxy for what would be the most relevant measure; 
antibiotics consumption rate. Prescriptions may have been picked up without the 
patient having taken the medication, and also, patients may have acquired and 
consumed antibiotics from other sources (105) and hence omitted to fill the 
prescription registered in the EMR dataset. However, registered antibiotics dispensing 
rate is the closest we can get to consumption rate without using patient self-report, 
which may be unreliable (106) and would be too resource-intensive for such a large 
trial, or electronic measurement devices (106), which also would be impossible to 
implement in terms of resources.  
 
Paper II – The focus group study 
We used established CME groups as focus groups, for several reasons. First, we 
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expected that the participants knew each other well and respected each others views, 
creating a atmosphere in which the participants could speak freely. Second, the Rx-
PAD Study intervention was conducted on a CME group level, the members had 
already revealed and discussed each others prescribing patterns, and might challenge 
discrepancies between expressed beliefs and actual behaviours. Third, the CME 
groups had an established form, meeting location and meeting time, and the members 
were given meriting points also for the focus group interview, warranting that the 
participants would show up and stay for as long as the interview lasted. On the other 
hand, we anticipated that divergent views also might be suppressed in established 
groups, which led us to include one purpose-constructed group (93). 
 
Reflexivity 
My role and my preconceptions may have had an influence on the participants 
expressed views on delayed prescribing. In order to challenge our own 
preconceptions, all authors took part in the analysis, and we agreed on the results. In 
addition to having some of my expected findings confirmed, I also discovered 
diverging and unexpected views and experiences.   
My preconception that the participating GPs were concerned with prudent 
prescribing was confirmed. However, I was surprised to find that delayed prescribing 
was not foremostly seen as a means to lower unnecessary antibiotics use, but as a 
practical solution at the individual patient level, e.g. helping the patient avoid seeking 
after-hours care. As expected, there were divergent opinions on the strategy, but we 
did not find that the proponents were more concerned with prudent prescribing than 
the opponents. Rather, both sides made references to prudent prescribing to support 
their view.  
 
Paper III – The questionnaire study 
The response rate (80%) was relatively high compared to a similar study by Edwards 
(32). This may be caused by the difference in deliverance of the questionnaire; in our 
study, the GP handed the patient the questionnaire, while in Edwards’ study, the 
questionnaire was sent by second class post.  
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The GP and patient questionnaires were not validated. We acquired a patient 
questionnaire used in the study by Edwards (32), in order to be able to compare our 
results.  
The aim of this study was not to explore clinical outcomes and safety of the 
delayed prescribing strategy, and potential differences in treatment outcomes for 
different diagnoses have not been investigated. This study does not allow to directly 
compare the use of wait-and-see prescriptions with the use of prescriptions for 
antibiotics to be taken immediately, since we have no record of the latter.  
As in all questionnaire surveys, our results depend on the respondents report, 
and not necessarily on their action. The patient questionnaire and information leaflet 
were carefully constructed to avoid an impression that not picking up the prescription 
would be the preferred solution, as to minimise a social desirability bias (107). Still, the 
reported antibiotics consumption rate of 46% may be an underreporting of what 
actually happened.  
 
Acceptability of delayed prescribing 
In the focus group study, we found that GPs viewed delayed prescribing an acceptable 
strategy, but to a varying degree. The GPs who endorsed delayed prescribing the most, 
found that it was useful in empowering and educating the patient. Other GPs said that 
they mainly used delayed prescribing in what they experienced as an uncomfortable 
situation of being forced to prescribe antibiotics, and were more negative towards the 
strategy. 
The questionnaire study strengthens the validity of these results. In the few cases 
where delayed prescribing was used because of treatment disagreement with the 
patient, the GP was significantly less satisfied with the strategy compared to cases 
where delayed prescriptions were issued for other reasons.  
The findings are similar to those of Arroll et al (66), who found that delayed 
prescribing was considered a useful strategy in decreasing unnecessary antibiotic use, 
empowering patients, strengthening the physician–patient relationships, and securing 
convenience for the patients. However, Arroll’s study setting was patients with 
common cold, whereas our participants did not see this diagnose as suitable for 
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delayed prescribing.  
In 2011, Peters et al (61) conducted a comprehensive qualitative study of the 
usefulness of the delayed prescribing strategy within UK primary care. The 
participants commonly found RTI consultations confrontational, due to a perception 
that patients expected antibiotics, and the prescribers did not trust patients to fill the 
delayed prescriptions only if the condition worsened. The prescribers generally felt 
uncomfortable about using delayed prescribing, and reported using the strategy 
infrequently. 
These results are similar to the views held by the GPs most reluctant to delayed 
prescribing in our focus group study. When stating that delayed prescribing mainly 
was acceptable to our selection of GPs, this is based on a setting where the GPs 
generally did not consider RTI consultations as confrontational.  
Accordingly, the acceptability of delayed prescribing varies both between 
different settings and different GPs. In the intervention study, delayed prescribing 
were more often used by women, group practitioners and GPs without speciality in 
general practice than men, solo practitioners and GP-specialists. However, none of 
these differences were significant in the adjusted logistic regression analysis. A 
common view among the focus group GPs was that doctors with a paternalistic 
decision-making style would not accept the strategy. However, the results do not 
support that GPs reluctant to delayed prescribing have a paternalsitic style, neither that 
delayed prescribing was used to ensure the opposite decision-making style (44); the 
informed choice model, or the middle ground between these models; the shared 
decision-making model. A strong view among the participants was that patients 
receiving a delayed prescription should be instructed thoroughly in the criteria for 
starting to take the antibiotics. Hence, delegation of authority, rather than sharing the 
decision or informing for a free choice, is a relevant term for the GPs understanding 
of delayed prescribing. Although the participants made references to informing and 
empowering patients as an argument for delayed prescribing – terms associated with 
patient-centered care and shared decision-making – the GPs generally held that the 
decision whether the patient should consume the antibiotics was theirs, through clear 
instructions and based on the course of the condition. Also, the decision whether to 
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issue a delayed prescribing was commonly referred to as the GPs decision. When 
diverging views on the necessity of antibiotics led to delayed prescribing, the GP 
referred to this as a lost discussion rather than a common agreement. 
Charles et al (44) have suggested four key characteristics of shared decision-
making: 1) At least two participants (physician and patient) are involved. 2) Both 
parties share information. 3) Both parties take steps to build a consensus about the 
preferred treatment. 4) An agreement is reached on the treatment to implement. 
Elwyn et al (45) have questionned the feasibility of the model in consultations in 
which conflict occurs between patients and prescribers about the necessity of 
antibiotics for RTIs, and refers to delayed prescribing in this context as giving mixed 
messages in order for the GP to preserve his/her standpoint when an agreement can 
not be reached. Although agreement was the rule rather than the exception for the 
focus group GPs, Elwyn et al’s critisism matches our findings. 
With the “delegated authority”-perception in mind, the GPs inevitably had 
several requirements to the patient in order to issue delayed prescriptions, ie be 
“knowledgeable” and not demanding antibiotics for conditions not warranting their 
use.  
The focus group GPs stated that delayed prescribing was well in line with what 
they saw as one of the principles of general practice; to find good solutions when 
facing practical challenges. The practical challenge in this setting was mainly that the 
patient consulted at a stage in the course of the condition where the indication for 
antibiotics could not be established, and the “good” in the solution of delayed 
prescribing was mainly to allow the patient to avoid the burden of a reconsultation. 
The questionnaire study confirms this, as 79% of the delayed prescriptions were issued 
because of “Uncertainty about indication for antibiotics” or “Difficulties with follow 
up”.  
We have described two main reasons for issuing delayed prescriptions, in 
addition to reducing antibiotics use: Arroll’s patient request for antibiotics, which can be 
linked to the ethical principle of respect for autonomy, and Little’s safety netting, which can 
be linked to the ethical principle of beneficence. As seen, our selection of GPs seem to be 
more pleased with a decision based on the principle of beneficence rather than the 
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principle of autonomy in this area. This may, as we have seen, been due to the GPs’ 
experience that patient request for antibiotics is a minor challenge. One may also 
speculate that the ethical principles are weighted differently in different settings. A 
Scandinavian criticism of the ethical principle model is that autonomy is given too 
much weight at the expense of beneficence (108). 
 
To conclude, delayed prescribing is generally regarded as an acceptable and 
practical strategy to reserve antibiotics for the cases for whom the GPs find them 
indicated. It is restricted to patients found capable of being delegated the authority to 
evaluate the indication for antibiotics after a certain amount of days. This capability 
depends on whether the patient shares the GPs views on prudent prescribing. If their 
views are not in line, delayed prescribing is still used, but to a smaller extent, and with 
less satisfied GPs. 
GPs views on, and reasons to use, delayed prescribing seems to vary according 
to the GPs’ setting. Researchers should evaluate this prior to educational interventions 
involving recommendation of delayed prescribing. There is a lack of knowledge on 
patients’ views on and experiences with delayed prescribing. This should be explored 
in both high- and low antibiotics consuming settings.  
   
GPs’ use of delayed prescribing  
Frequency 
The focus group GPs stated that they had a set of requirements both to the patient, 
the situation and the clinical presentation in order to issue a delayed prescription, 
hence delayed prescribing was not seen as a strategy to be used in most cases of RTIs. 
This is reflected in the intervention study; only 11% of the patients given an antibiotic 
prescription for RTI, or 3% of all RTI patients, were given a delayed prescription.  
In New Zealand, Arrol et al (62) found that GPs not exposed to any formal 
recommendation of delayed prescribing, reported that they would prescribe delayed 
prescriptions for a median of 10% of patients with upper RTI. Also, in a British 
questionnaire study (32), Edwards et al found that approximately 10% of RTI patients 
were given delayed prescriptions.  
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In the intervention study, 7.2% of the prescriptions for acute bronchitis were to 
be delayed. An observational study on delayed prescribing for acute cough in 14 
primary care networks in 13 European countries (64) found that 11.8% of the patients 
that received a prescription received a delayed prescription. The rate for the 
participating Norwegian network was 6.6%, thus very close to our findings. Acute 
cough and acute bronchitis are not interchangeable categories, and participants in the 
observational study were not encouraged to use delayed prescribing. Nevertheless, a 
comparison with this study may indicate that the use of delayed prescribing is even 
more infrequent in Norway than in Europe as a whole. This may be related to the low 
antibiotic prescription rate in Norway; GPs in our setting may prefer a no-antibiotic 
option in cases where other GPs might prefer delayed or immediate antibiotics. In the 
Norwegian network, antibiotics were prescribed in 30% of the consultations, whereas 
the rate for all networks was 52.4%. Although old figures, antibiotic prescribing rates 
for URTIs in New Zealand has been found to be as high as 77.5% (109).  
Also, GPs’ limited use of delayed prescribing in the intervention study may be 
due to the relatively low patient demand – and GPs’ perceived patient demand – for 
antibiotics in our setting. Both New Zealand and UK GPs report that patients 
generally expect antibiotics for RTI (36, 61), while our focus group GPs experienced 
that patients were happy to avoid antibiotics. In the questionnaire study, 52% of the 
patients reported that they expected the GP to prescribe antibiotics, compared to 65% 
in a corresponding British study (32). In a study from a large Norwegian emergency 
centre, as few as 38% of the patients consulting for RTIs reported that they expected 
antibiotics (110).  
 
Diagnoses 
One may ask if it is of importence to explore differences between the different RTI 
diagnoses. The British NICE guideline (26) advices are essentially common for all so 
called self-limiting RTI diagnoses. It has been hypothesised that sinusitis, URTI and 
acute bronchitis are variations of the same clinical condition (111). However, our 
studies show that the patients diagnosis is of great importance both when it comes to 
acceptability, prescribing and dispensing of delayed prescriptions. 
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The three studies were consistent regarding the most eligible diagnoses for 
delayed prescribing; acute sinusitis and acute otitis media. In the intervention study, 
19.2% and 13.3% of the antibiotics were to be delayed for acute otitis media and acute 
sinusitis, respectively. In the broad category of URTI and RT symptoms, the 
corresponding rate was 16.3%. As discussed, this category is heterogenic. In absolute 
numbers, delayed prescriptions was most commonly issued for URTI and RT 
symptoms, followed by sinusitis, otitis and bronchitis. 
Most studies on delayed prescribing are diagnosis-specific, hence there is a scarce 
basis of comparison for these findings. A small Canadian study (56) found a quite 
similar distribution; the most common condition which triggered delayed prescribing 
was URTI, followed by sinusitis, bronchitis, and pharyngitis. When examining which 
diagnoses have been tested in RCTs on delayed prescribing as a tool to lower 
antibiotics use (43), three trials are on acute otitis media, two on bronchitis/cough, 
one on common cold and one on sore throat. The reasons given for conducting these 
trials are generally that the specific condition is common in general practice, and that it 
often is treated with antibiotics, despite a marginal clinical effect. In one of the 
bronchitis trials, LRTI is said to be the most common condition treated in UK 
primary care, and that excess antibiotic prescribing in the US mainly is for this 
condition together with pharyngitis (51).  
This seems not to be the case in Norway. There is no reason to believe that there 
are great differences between UK and Norway regarding the incidence of different 
RTIs. However, lay people’s understanding of illnesses and their threshold to consult, 
as well as doctors’ diagnostic labelling, may vary greatly between cultures and countries 
(112, 113). URTIs is by far the most common infectious condition in Norwegian 
primary care, and both this condition – despite a low antibiotic prescribing rate of 
15.6% – and acute sinusitis generates more antibiotics prescriptions than bronchitis, 
which is at the same level as acute otitis (20). These factors may offer some 
explanation of the relatively high number of delayed prescriptions for URTI, otitis and 
sinusitis found in our studies.  
Although sore throat was the object of the first trial on delayed prescribing (49), 
leading to much attention, only 5.6% of the patients receiving antibiotics for this 
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condition in the intervention study were instructed to delay. This may be related to the 
widespread use of StrepA point-of-care-test in Norwegian primary care (114). When in 
doubt, GPs probably let the test result guide the decision whether to prescribe 
(immediate) antibiotics or not, instead of issuing a delayed prescription. 
The focus group GPs described characteristics of conditions suitable for delayed 
prescribing. First, it should have a certain, or at least a possible, bacterial etiology. 
Second, there should be an expectation that the indication for antibiotics would be 
established within a few days, dependent on the course of the condition. Both these 
characteristics match the understanding of acute sinusitis and acute otitis found in the 
Norwegian treatment guidelines for RTIs in primary care (87). Sinusitis and otitis are 
the only conditions in which the duration of symptoms determine whether antibiotics 
are indicated (seven days and one to three days, respectively). Even though the 
guidelines were not mentioned by our participants, they have to some degree been 
familiar with the content. Their preferral and relatively frequent use of delayed 
prescribing for sinusitis and otitis may be an indication that they used the strategy as a 
way to adhere to treatment guidelines.  
 
Age 
The focus group GPs did not express any strong opinions as to which age groups 
were most eligible for delayed prescriptions, apart from the notion that the eligible 
diagnosis of acute otitis mainly occurs in children. In the intervention study, children 
below 13 years had the highest delayed prescribing rate; more than 15% of the 
antibiotic prescriptions issued were to be delayed, while the corresponding rate for the 
age groups above 44 years were 4,6 – 8 %. In the logistic regression analysis, patients 
above 18 years had significantly lower odds of receiving antibiotics to be delayed 
compared to the reference age group of 0-6 years. In New Zealand, Arroll et al found 
that GPs generally restricted the use of delayed prescriptions to a particular age range, 
but they did not agree about what age range this should be.  
Children differ from adults in several ways as regards to antibiotics use for RTIs. 
Even though children are prescribed more antibiotics than adults in primary care, 
antibiotic prescription rates are lower for children than for adults (20, 65), due to a 
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higher visit rate for children than for adults. This can partly explain the higher delayed 
prescribing rate among children found in our study; children may have milder 
symptoms than adults when visiting the GP, which may increase the GP’s likelihood 
of instructing the parents to wait and see when issuing antibiotics. Second, the 
distribution of diagnoses in the different age groups obviously influences on the 
delayed prescribing rates for the corresponding age groups. Thirdly, the focus group 
GPs experienced that parents generally were sceptical about antibiotics, possibly 
increasing the likelihood of being prescribed delayed antibiotics for their children.   
 
To conclude, even though being encouraged to use the strategy, GPs only 
adviced to delay 11% of their antibiotics prescriptions for RTI. The diagnoses found 
most suitable for delayed prescribing, were acute otitis and acute sinusitis; the only 
diagnoses for which symptom duration determines indication for antibiotics, 
according to Norwegian guidelines.  
GPs should be encouraged to use delayed antibiotic prescribing as a tool to 
adhere to the current guidelines for antibiotic use in primary care. The adviced delay 
should correspond to the guidelines’ recommended symptom duration determining 
indication for antibiotics, ie one – three days for acute otitis and seven days for acute 
sinusitis.  
There is a lack of knowledge on the clinical outcome of delayed prescribing for 
acute sinusitis. This should be evaluated in a randomised controlled trial.  
 
Patients’ filling of antibiotic prescriptions 
Our studies reports several different measurements on patients’ filling of antibiotic 
prescriptions. The questionnaire study measures patients’ self-reported filling and 
consumption of delayed antibiotics. The intervention study measures patients’ filling 
of delayed and regular prescriptions, but also the filling of prescriptions issued in the 
baseline period, and by GPs in the control groups – hence prescriptions that are not 
defined as delayed or regular. First, we will discuss the latter. 
Primary medication non-adherence, ie new medication not picked up, is 
normally seen as an unwanted phenomenon. There are wide variations in the reported 
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prevalence of primary non-adherence in different study settings, from 2.5% (115) to 
35% (116). The appearance of e-prescriptions has made it easier to study primary non-
adherence. In USA, Fischer et al (117) found that 72% of 82,245 e-prescriptions for 
new medications were filled, while the fill rate for antimicrobial drugs was 80%. In 
Sweden, Ax et al (115) found that as much as 97.5% of the prescriptions were filled, 
while 96.5% of the antibiotics were filled. Our baseline antibiotic-dispensing rate of 
92.1% is towards the higher end of the spectre, close to the Swedish numbers. High 
antibiotic adherence rates in the Nordic countries have been commented earlier (104), 
without any conclusion. One may speculate whether this is related to the high levels of 
social and political trust found in the Nordic countries (118), which also implies trust 
in authorities such as doctors. Deschepper et al (119) have demonstrated a correlation 
between a country’s antibiotic use and the country’s score on the cultural dimension of 
Power distance. In countries with low Power distance, such as the Nordic countries, 
authority is based on rational arguments, and there is a high degree of equality 
between subordinates and superiors. A patient-doctor relationship characterised by 
trust and equality may result in high adherence. 
Patients may have had a variety of reasons for not filling the 2775 (7.9%) 
prescriptions. A proportion may have been issued as delayed prescriptions. Also, the 
focus group GPs had a common experience that patients may delay or refuse 
antibiotic treatment on their own initiative, without the GP’s advice (not reported in 
the paper). Certainly, some prescriptions also have been unclaimed unintendedly, ie 
due to leftovers, misunderstandings, oversight etc.  
Consumption rates of antibiotics are considerably lower than dispensing rates. A 
meta-analysis found an overall antibiotics adherence rate of 62.2% (105), and a recent 
study on adherence to prescribed antibiotics for acute cough found adherence to at 
least a three-day course in only 57.8% of patients (104). The adherence rate varied 
across the different European networks participating in the study, with the highest 
rates being in the Scandinavian countries (Norway: 85.7%).  
We found that both patients’ age and diagnose influenced on the dispensing rate. 
Consistent with other studies, the dispensing rates were lowest in the youngest age 
groups (102, 115). Accordingly, GPs in the focus group study experienced that parents 
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commonly were sceptical about antibiotics. The diagnoses with the lowest dispensing 
rates were equivalent to the diagnoses found most eligible for delayed prescribing; 
sinusitis, otitis and URTI and RT symptoms. This indicates that the GPs to some 
extent used delayed prescribing for these conditions also prior to the intervention. 
 
Filling of delayed prescriptions 
The reported consumption rate for delayed prescriptions in the questionnaire study 
was 46%, and the dispensing rate in the intervention study was 59.2%. The latter is 
higher than any consumption rate reported in randomised controlled trials (RCTs) or 
surveys on delayed prescribing for RTIs (24% (53) – 53% (32)). There are several 
possible explanations for this high rate. The GPs in our study may have been less 
emphatic in delivering the wait-and-see advice to patients compared to GPs in RCTs 
or surveys on delayed prescribing. Also, the patients in our study were not aware that 
they were observed, hence there were no possibility of a social desirability bias. 
Furthermore, the patients in our study were given the delayed prescription at the time 
of their consultation, whereas in many of the delayed prescribing RCTs, patients had 
to return to their GP’s office to pick up the prescription (50, 53, 54). The latter 
strategy results in lower consumption rates; 40% vs 28%, respectively. Finally, patients 
in our study may have filled the prescription for antibiotics but not consuming the 
medication. Figures from a British questionnaire study and our own questionnaire 
study show that respectively 15% (32) and 11% of patients stated that they did not 
consume the antibiotics, even though they had filled their delayed prescription. 
Applied to the intervention study, this corresponds to a 50–53% consumption rate.  
Both in the questionnaire and the intervention study, delayed prescriptions were 
least likely to be filled in cases of otitis. This may be due to the natural course of this 
condition – approximately 80% of the cases of acute otitis in children results in a 
spontaneous recovery after a few days (24), whereas other RTIs may not have this 
sudden relief. Both studies also showed a clear association between age and 
prescription filling. In the questionnaire study, the adjusted odds ratio for reporting to 
consume antibiotics was 2,2 – 2,9 for the age groups above 16 years compared to the 
reference age group 0-16 years, while the intervention study showed a dispensing rate 
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of 66 – 94% for patients in the age groups above 44 years, and corresponding rates of 
45 – 54% for patients below 19 years. Both parents scepticism towards antibiotics, the 
distribution of diagnoses in the different age groups and presumably milder symptoms 
among children may explain these differences.  
 
To conclude, both delayed prescriptions and prescriptions not recorded as 
delayed or immediate, are most often unfilled among children, and in cases of acute 
sinusitis, acute otitis and URTI and RT symptoms. Hence, delayed prescribing’s 
potential in decreasing antibiotics consumption is largest within these areas.  
GPs should be aware of this, and also that only around half of the patients 
receiving delayed prescriptions in routine care will consume the antibiotics. GPs 
should take into account that a not negligible proportion of patients do not dispense 
their regular antibiotic prescriptions. For patients in dire need of treatment, GPs 
should take steps to assure that the patient adheres to the treatment plan. For other 
patients, this “appropriate non-adherence” should be both explored and utilised.    
 
Effectiveness regarding lower antibiotics use 
 When tested in RCTs, delayed prescribing leads to a substantial reduction in 
consumed antibiotics (43). However, this is not to say that delayed prescribing has the 
same antibiotic saving potential when implemented in routine care. The effectiveness 
in routine care depends both on the patients’ prescription filling in a setting where 
he/she is not aware of being observed, and whether the efforts to implement the 
strategy succeed. As to the first question, we have seen that approximately half of the 
delayed antibiotics will be consumed.  
The remaining question is whether our efforts to implement delayed prescribing 
had an influence on the GPs behaviour. There has been a concern that implementing 
delayed prescribing will lead to more, rather than less, antibiotics consumption for 
RTIs. Although our focus group participants did not think it applied to them, some 
GPs mentioned that delayed prescribing might give a slippery-slope effect, leading 
patients to demand antibiotics for every RTI, thereby resulting in increased antibiotics 
consumption. In Peters and al’s qualitative study from the UK (61), the participating 
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prescribers found it unlikely that delayed prescribing reduces antibiotic use. Others 
have shared this concern (50).  
In our setting, this concern seems to be unjustified. The pop-up intervention 
GPs did not prescribe antibiotics more frequently than their controls; both groups 
issued antibiotics in 29,3% of the RTI consultations. Hence, it seems that when GPs 
are encouraged to use delayed prescribing, they replace immediate prescriptions with 
delayed prescriptions, rather than replacing a no-antibiotics option with delayed 
prescriptions. This was in line with the recommendations given as a part of the 
intervention. There are however two conditions to be taken into account when 
interpreting this result. First, the pop-up reminder was triggered upon issuing a 
prescription, hence it was first after the decision to prescribe that the GP was 
reminded on the delayed prescribing option. Second, the constant reminding of 
delayed prescribing may also have reminded the GP that their prescribing rate was 
registered, possibly influencing on this rate through the Hawthorn effect.  
When introducing innovations to improve quality of care, the nature of the 
innovation must be taken into account. Incentives of change include the feasibility, 
credibility, accessibility and attractiveness of the innovation (28, 120). The focus group 
study stated that delayed prescribing is a method that suits well with the practice style 
and the way to do things in general practice. Many participants stated that they had 
come up with the idea of delayed prescribing early in their career, as a practical tool. 
This is in accordance with New Zealand findings (66). Others told that they had 
started using the strategy after hearing it recommended as part of the RxPAD study 
intervention. However, the credibility and attractiveness of the innovation were 
questioned by some of the GPs, and all agreed that delayed prescribing was feasible 
only to certain patients, under certain circumstances. Hence, we had no expectations 
of major changes in the participants use of delayed prescribing.  
In terms of antibiotic-dispensing rates, we found no significant effect of the 
educational intervention. That is, the intervention did not seem to significantly 
increase participants’ use of delayed prescribing. In the educational intervention, 
delayed prescribing was mainly advocated to GPs through passive dissemination of 
recommendations, ie a short lecture and a minor part of the group discussions. The 
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participants were not given details of their own use of delayed prescriptions and their 
patients fill rates, as they did with prescription rates and broad/narrow-spectrum 
prescription rates. Interventions using passive dissemination of recommendations 
alone have generally had little effect in changing physicians’ behaviour (77). 
The pop-up intervention produced a small but significant decrease in 
dispensing rate, indicating that the pop-up reminder increased the use of delayed 
prescribing. The absolute reduction in dispensing rate between the pop-up 
intervention group and the control group was 2.2%, and between the pop-up 
intervention group and the educational intervention 1.6%. A Cochrane review of on-
screen, point-of-care computer reminders concludes that such interventions generally 
result in small to modest improvements in provider behaviour (121). In multifaceted 
interventions that aim to improve process adherence, the median effect of the 
computerised reminder alone was 1.9%, thus in line with our results.  
Another way to interpret the effect of the intervention is to estimate the use of 
delayed prescriptions for the educational intervention control group and the pop-up 
intervention control group. Assuming that antibiotics to be taken immediately were 
dispensed in 94,3% of the cases and that delayed prescriptions were dispensed in 
59.2% of the cases in all three groups, based on the figures from the pop-up 
intervention group, the delayed prescribing rate in the educational intervention control 
group would be 5,4% and in the pop-up intervention control group 7,1%, compared 
to 11% in the pop-up intervention group. Although these figures are based on 
assumptions, they suggest that the use of delayed prescribing might have doubled as a 
result of the interventions. 
We have not found other intervention studies aimed at implementing delayed 
antibiotic prescribing in routine care. Six months after a Scottish RCT on delayed 
prescribing for acute cough (50), 68% of the recruiting GPs reported that they had 
continued to issue delayed prescriptions at least monthly. In Francis et al’s 
comprehensive observational study on delayed prescribing for acute cough (64), GPs 
of the Southampton network more often issued delayed than immediate prescriptions. 
This network was linked to a university department that had conducted many studies 
of delayed prescribing. As it seems, GPs “forced” to issue delayed prescriptions due to 
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participation in trials, continue to use the strategy. However, this is not a feasible 
implementation strategy. 
McDermott and co-workers (122) developed a computer-delivered intervention 
to promote the implementation of guidelines in general practice, including the NICE 
guidelines that recommends delayed prescribing for RTIs (26). As described in the 
Methods-section, the computerised pop-up software used in our intervention study 
was originally developed as a mere registration tool. Initially we did not set out to test 
whether this software was an implementation tool to recommend. Hence, no special 
efforts were put down in order to make the pop-up effective in influencing the GP to 
choose delayed rather than immediate prescribing; The pop-up window only 
contained a simple question on whether the prescribed antibiotic was a delayed or a 
regular prescription (Appendix E). This is clearly a disadvantage of the intervention 
study, and may partly explain the modest effect of the intervention. On the other 
hand, GPs may prefer computer-delivered interventions that are neutral and allow 
choice, as demonstrated by McDermott and co-workers (122). Also, as previously 
discussed, the effect of the pop-up reminder is in line with the effect found in other 
studies on computerised reminders. 
As described in the Introduction section, there exists huge disagreements as to if 
delayed antibiotic prescribing should be promoted at all. The authors of the Cochrane 
review on delayed prescribing (43) seem to find no reasons to recommend the 
strategy. They conclude that when the GP feels that it is safe not to prescribe 
antibiotics immediately, no – rather than delayed – antibiotics will give the best result; 
the same level of clinical outcomes and patient satisfaction as delayed prescribing, but 
lower antibiotic consumption. Still, the NICE guidelines on antibiotic prescribing for 
RTIs in primary care (26) recommend delayed prescribing as an equally good option as 
no prescribing in RTI cases where the patient is not at risk of developing 
complications. Our studies were carried out within the setting of an educational 
intervention study mainly aiming at a no antibiotics option, according to the 
Norwegian guidelines on the treatment of RTIs in general practice. In this setting, 
efforts to implement delayed antibiotic prescribing did not seem to weaken the no 
antibiotics recommendation. This demonstrates that there is a niche for delayed 
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prescribing as an antibiotic saving strategy, forming a middle ground between the 
Cochrane review conclusion and the NICE guidelines: A no antibiotics option is to be 
preferred for RTI patients who do not need antibiotics immediately. Delayed 
antibiotics is the second choice, and is suitable especially for conditions in which 
symptom duration is of importance regarding indication for antibiotics.  
 
To conclude, promoting delayed prescribing for RTIs in routine care results in 
decreased antibiotics dispensing, without any increased antibiotic prescribing. Given 
the relatively small absolute effect of the combined educational- and pop-up 
intervention on dispensing rate, we do not recommend this as an intervention to be 
used alone. However, as a part of multi-faceted interventions to decrease antibiotics 
prescribing for RTIs, strategies to increase the use of delayed prescriptions seem to 
give an additional effect in decreasing dispensed, and thereby consumed, antibiotics. 
When advocating delayed prescribing, this should allways be accompanied by a firm 
message that no antibiotics is the preferred option for RTIs that do not fill the 
requirements of immediate antibiotics at the time of the consultation. 
Researchers should evaluate the effect and the cost-effectiveness of other 
interventions to promote delayed prescribing, both in low- and high antibiotics 
consuming settings.  
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Conclusion 
In conclusion, this thesis suggests that 
x GPs find delayed prescribing an acceptable strategy for reserving antibiotics to 
the cases where it turns out to be medically indicated, according to current 
treatment guidelines. 
x GPs have strict requirements as to which patients, for which diagnoses and in 
which situations they will issue delayed prescriptions, resulting in an infrequent 
use of the strategy. 
x Delayed prescribing is less effective in reducing antibiotics use in routine care 
than in a trial setting, but still only about half of the delayed antibiotics will be 
consumed. 
x The strategy’s potential in reducing antibiotics use is largest in cases of acute 
otitis and acute sinusitis.  
x Efforts to promote delayed prescribing give a small decrease in dispensed 
antibiotics, without any accompanying increase in prescribed antibiotics. 
 
The messages to health authorities, postgraduate GP teachers and other entities 
working to promote prudent antibiotics use are: 
x The use of delayed prescribing as a tool to adhere to treatment guidelines 
should be encouraged, especially in cases of acute otitis and acute sinusitis.  
x A computerised pop-up reminder on delayed prescribing is not recommended 
as a sole intervention, but should be considered as an element in multi-faceted 
interventions. 
x When promoting delayed prescribing, this should always be accompanied by a 
firm message stating that no antibiotics is the preferred option for RTIs which 
do not fill the requirements of immediate antibiotics at the time of 
consultation. 
x The antibiotics saving potential of delayed prescribing seems to be low in our 
setting. This potential should be explored before deciding whether to promote 
the strategy in new settings.  
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Future research 
Our study suggests that there is need for research which:  
x Evaluates the clinical outcome of delayed versus immediate and no antibiotics 
prescribing for acute sinusitis in a randomised controlled trial. 
x Explores patients’ non-adherence to antibiotics, in order to produce knowledge 
on how and whether this non-adherence can be utilised to decrease antibiotics 
use.  
x Evaluates the effect and the cost-effectiveness of interventions to promote 
delayed prescribing in various settings.  
x Evaluates the effect and the cost-effectiveness of interventions to promote 
delayed prescribing using various intervention elements. 
x Explores patients’ views on and experiences with delayed prescribing in both 
high and low antibiotics consumption settings.  
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Use and feasibility of delayed prescribing for
respiratory tract infections: A questionnaire
survey
Sigurd Høye1*, Jan C Frich2 and Morten Lindbæk1
Abstract
Background: Delayed prescribing of antibiotics for respiratory tract infections (RTIs) lowers the amount of
antibiotics consumed. Several national treatment guidelines on RTIs recommend the strategy. When advocating
treatment innovations, the feasibility and credibility of the innovation must be taken into account. The objective of
this study was to explore GPs use and patients uptake of wait-and-see prescriptions for RTIs, and to investigate the
feasibility of the strategy from GPs’ and patients’ perspectives.
Methods: Questionnaire survey among Norwegian GPs issuing and patients receiving a wait-and-see-prescription
for RTIs. Patients reported symptoms, confidence and antibiotics consumption, GPs reported diagnoses, reason for
issuing a wait-and-see-prescription and their opinion about the method.
Results: 304 response pairs from consultations with 49 GPs were received. The patient response rate was 80%. The
most common diagnosis for the GPs to issue a wait-and-see prescription was sinusitis (33%) and otitis (21%). 46%
of the patients reported to consume the antibiotics. When adjusted for other factors, the diagnosis did not predict
antibiotic consumption, but both being 16 years or more (p = 0,006) and reporting to have a fever (p = 0,012)
doubled the odds of antibiotic consumption, while feeling very ill more than quadrupled the odds (p = 0,002). In
210 cases (69%), the GP found delayed prescribing a very reasonable strategy, and 270 patients (89%) would prefer
to receive a wait-and-see prescription in a similar situation in the future. The GPs found delayed prescribing very
reasonable most frequently in cases of sinusitis (79%, p = 0,007) and least frequently in cases of lower RTIs (49%, p
= 0,002).
Conclusion: Most patients and GPs are satisfied with the delayed prescribing strategy. The patients’ age, symptoms
and malaise are more important than the diagnosis in predicting antibiotic consumption. The GP’s view of the
method as a reasonable approach depends on the patient’s diagnosis. In our setting, delayed prescribing seems to
be a feasible strategy, especially in cases of sinusitis and otitis. Educational efforts to promote delayed prescribing
in similar settings should focus on these diagnoses.
Background
General practitioners (GPs) issue more than 90% of
antibiotic prescriptions in Norway, and about 60% of
these are issued for common respiratory tract infections
(RTIs) [1]. RTIs are often self-limiting, and antibiotics
have a modest role in the treatment of such conditions
[2]. Unnecessary use of antibiotics is a global concern,
as it leads to antibiotic resistance, adverse drug reac-
tions, and medicalization of self-limiting disease. Anti-
biotic prescription rates are relatively low in Norway
and other Northern European countries [3], but a recent
Norwegian prescription study found that there still is
room for improvement [4].
Much effort has been put into developing strategies to
reduce over-consumption of antibiotics for RTIs in gen-
eral practice, and randomized controlled trials have pro-
vided evidence for delayed prescribing as an effective
strategy. Reported pick up rates for wait-and-see pre-
scriptions varies from 24 - 38% (otitis media) [5,6], 31%
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(sore throat) [7], 20 - 45% (cough) [8,9], to 48% (com-
mon cold) [10]. The safety of the method seems to be
good, and there is probably no increase in complication
rates, but a longer duration of certain symptoms in
some studies [11].
It has been argued that delaying antibiotics has little
advantage over avoiding them where it is safe to do so
[11]. However, the question regarding safety in handling
RTIs is not clear cut, and factors like physician insecur-
ity, patient demands and work load lead GPs to pre-
scribe antibiotics without a good medical indication
[12]. GPs experience numerous situations where they
find delayed prescribing reasonable [13]. Hence, delayed
prescribing might have an important place in the man-
agement of RTIs [14]. The strategy is recommended in
several national treatment guidelines on RTIs in general
practice [15-17], and it is part of the intervention in
quality improvement studies on appropriate antibiotics
prescribing [18-20].
Delayed prescribing is not universally endorsed by GPs
[13,21], though patients seem to be confident and satis-
fied with wait-and-see prescriptions [7,22]. When advo-
cating treatment innovations to improve quality of care,
the feasibility and credibility of the innovation must be
taken into account [23]. There is a lack of knowledge
on if, and in which situations, GPs find delayed prescrib-
ing a reasonable approach, and in which situations GPs
choose to use the strategy.
The aim of this study is to explore GPs use and
patients uptake of wait-and-see prescriptions for RTIs,
and to investigate the feasibility of the strategy from
GPs’ and patients’ perspective.
The terms “delayed prescribing” and “wait-and-see
prescription” are used synonymously in the literature. In
this paper we use “delayed prescribing” for the strategy,
and “wait-and-see prescription” denotes the prescription
itself.
Methods
Subjects and setting
We translated and adopted a questionnaire on patients’
response to delayed prescription used in a previous
study [22], and developed a questionnaire on GPs rea-
sons for issuing wait-and-see prescriptions.
The study was conducted as a part of the Prescription
Peer Academic Detailing (Rx-PAD) Study, a cluster-ran-
domized educational intervention study in Norwegian
general practice with the aim of improving antibiotic
prescribing in respiratory tract infections [18]. The ele-
ments of the intervention were educational outreach vis-
its to the participants’ continuing medical education
groups comprising presentation and discussion of evi-
dence-based antibiotics prescribing for RTIs, collection
of individual prescription data, audit based on individual
feedback reports, as well as a one-day regional seminar.
As part of the seminar, one of the authors (SH) gave a
lecture on the evidence regarding delayed prescribing,
and invited the GPs to recruit patients to the present
study. 58 GPs agreed to participate. In addition, 16 GPs
affiliated to the Department of General Practice, Univer-
sity of Oslo, were given the same lecture, and agreed to
participate (Figure 1).
Eligible patients were those of any age who consulted
the GP for a RTI, and to whom the GP found it appro-
priate to offer a wait-and-see prescription. In the course
of the consultation, the GP handed the patient an anti-
biotic prescription together with a patient questionnaire,
a consent form, an information leaflet and a pre-
stamped envelope. The patient was instructed to wait
for a certain amount of time, chosen by the GP, before
deciding whether to take the antibiotics or not. The
questionnaire was to be filled once the patient had
made this decision. After the consultation, the doctor
filled in the GP questionnaire. Patients were rewarded
with a scratchcard upon responding, while the GP
would receive a gift card for a CD when they had
recruited 10 patients. Recruitment took place during
April 2006 through June 2008.
The Regional Committee for Research Ethics in Oslo,
Norway, approved the study (S-05272).
Statistical analysis
Chi square test was used to compare those patients who
reported to consume antibiotics and those who did not,
with regard to both patient factors (demographic char-
acteristics, presenting symptoms, expectations, confi-
dence in deciding whether to use the prescription) and
GP factors (diagnose, reason for giving wait-and-see pre-
scription, reasonableness, and impression of expecta-
tions and use of the prescription). Logistic regression
analysis was performed with the dependent variable
being whether the patient reported to consume the anti-
biotics or not. Further, we compared cases where the
GP found delayed prescribing very reasonable and cases
where where the GP did not. A significance level of 5%
was applied. Analyses were performed using SPSS 14
and 18.
Material
Out of a total of 68 GPs, 49 (72%) recruited on average
8.5 patients each (median 6; span 1-34). 19 (28%) GPs
recruited no patients. We received 413 responses from
GPs and 332 responses from patients. Five patients
informed that they did not want to participate, and con-
sequently we removed the corresponding GPs responses.
For five of the patient responses, we did not receive a
corresponding GPs response, resulting in 327 response
pairs and a patient response rate of 80%.
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17 response pairs were excluded because the GPs had
included patients who were treated for other conditions
than RTIs, and an additional six response pairs were
excluded because the patients failed to answer whether
they had taken antibiotics. 304 response pairs remained
for analysis.
We grouped diagnoses according to previouos studies
on RTIs [1,24]. Table 1 displays the characteristics of
the participating patients and GPs.
Results
Comparison of responders and non-responders
Of the 81 non-responding patients, there were signifi-
cantly more men (47% vs 33%) and more patients with
upper RTIs (34% vs 20%), compared to the group of
responders.
Delayed prescribing - when and why
Table 2 shows the diagnoses given by the GPs when
issuing a wait-and-see prescription, and the diagnose
groups used in the further analysis. In comparison with
a reference material of antibiotic prescribing for respira-
tory tract infections in a Norwegian county during two
winter months in 2003, our material shows an overre-
presentation of sinusitis (33,2% vs 14,6%) and otitis
(21,4% vs 9,1%), and an underrepresentation of lower
RTI (13,5% vs 28,5%) and tonsillitis (7,9% vs 16,8%).
The majority (58%) of the children given a wait-and-
see-prescription had otitis, while the majority (49%) of
adults had sinusitis, and the elderly had lower RTI
(46%). Patients with the diagnosis of upper RTI reported
feeling more ill (p = 0,009), and patients with tonsillitis
felt less ill (p = 0,04) compared to patients with other
diagnoses.
The GPs reported that they issued wait-and-see pre-
scriptions mainly because of uncertainty about the indi-
cation for antibiotics (211 cases, 69%) or uncertainty
about the diagnose (32 cases, 11%). (See also table 4).
Difficulties connected to follow up was given as reason
in 29 cases (10%), and disagreement with the patient on
203 GPs participating in 
the Rx-PAD Study.
A total of 49 GPs 
participated
150 GPs attending the 
seminar and invited to 
participate in the present 
study.
16 GPs affiliated to the 
Department of General 
Practice, University of 
Oslo, invited to participate 
in the present study.
58 GPs agreed to 
participate.
10 GPs 
participated
39 GPs 
participated
Figure 1 Flowchart representing GP recruitment.
Table 1 Characteristics of participating patients and GPs
n (%)
Patients 304 (100)
Gender
Female 204 (67)
Male 100 (33)
Grouped age (years)
Less than 16 100 (33)
16-59 180 (59)
60 and over 24 (8)
GPs 49 (100)
Gender
Female 13 (27)
Male 36 (73)
Delayed prescriptions issued
1-4 prescriptions 19 (39)
5-9 prescriptions 12 (24)
10-19 prescriptions 13 (27)
More than 20 prescriptions 5 (10)
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the need for antibiotics in 12 cases (4%). In 44 cases
(14%), the GP reported “Other reasons”, and in 34 of
these cases, this was the only explanation for issuing the
wait-and-see prescription. “Other reasons” were in all
but one case described as clinical or therapeutic peculia-
rities in the specific situation (eg. mild symptoms, preg-
nancy, short duration of symptoms, other treatment
started).
Factors associated with the decision to consume
antibiotics
141 (46%) of the patients reported to consume the anti-
biotics. Diagnoses and patients’ factors associated with
consumption of antibiotics are presented in table 3.
There were no statistically significant differences
between those who reported to have consumed antibio-
tics and those who did not in respect of their gender or
their educational level.
Patients diagnosed with an ear infection were less
likely to consume antibiotics. Patients younger than 16
years were less likely to consume antibiotics (p = 0,04).
When reporting to have fever, patients were more likely
to consume antibiotics (p = 0,012). Also, a higher num-
ber of reported symptoms (p = 0,024) and more malaise
(p = 0,012) made patients more likely to consume
antibiotics.
The prognostic variables in table 3 resulting in a p-
value of 0,25 or less were included in a logistic regres-
sion analysis, together with the background characteris-
tics age, gender and educational level, the dependent
variable being whether the patient reported to consume
the antibiotics or not (Table 4). Symptom sum was not
included, as this variable was closely correlated to, and
also included, the individual symptoms. Four factors
were significantly associated with consuming antibiotics.
Having a fever, reporting to be very ill and being of
older age increased the odds, while a nasal congestion
decreased the odds of consuming antibiotics.
When asked whether they thought the patient would
take the antibiotics, the GPs answered yes in 51 (17%)
of the cases, no in 131 (43%) of the cases and that they
were uncertain in 122 (40%) of the cases. The GPs’ pre-
sumption was slightly correlated with the patients’
reported action (p = 0,025, correlation coefficient 0,166).
Feasibility of delayed prescribing
262 (86%) out of the 304 patients stated that they felt
confident in deciding whether to use the prescription,
Table 2 Diagnoses where GPs issued delayed prescription, compared to a reference material of antibiotic prescriptions
for respiratory tract infections
Reference (Vestfold study)
Diagnose group Diagnose ICPC-2 code n % (95% CI) % (95% CI)
Upper respiratory tract symptoms and infections 60 19,7 (15,3-24,2) 21,3 (20,0-22,6)
Cough r05 6
Sinus symptom/complaint r09 7
Throat symptom/complaint r21 4
Upper respiratory infection acute r74 43
Lower respiratory tract infections 41 13,5 (9,7-17,3) 28,5 (27,1-29,9)
Acute bronchitis/bronchiolitis r78 36
Pneumonia r81 4
COPD r95 1
Ear infections 65 21,4 (16,8-26,0) 9,1 (8,2-10,0)
Ear pain/earache h01 1
Ear discharge h04 1
Ear symptom/complaint other h29 1
Acute otitis media/myringitis h71 62
Sinusitis 101 33,2 (27,9-38,5) 14,6 (13,5-15,7)
Sinusitis acute/chronic r75 101
Acute tonsillitis 24 7,9 (4,9-10,9) 16,8 (15,7-18,0)
Strep throat r72 5
Tonsillitis acute r76 19
Other respiratory diagnoses 13 4,3 (2,0-6,6) 9,7 (8,8-10,6)
Laryngitis/tracheitis acute r77 4
Influenza r80 7
Respiratory infection other r83 2
Høye et al. BMC Family Practice 2011, 12:34
http://www.biomedcentral.com/1471-2296/12/34
Page 4 of 10
Table 3 Patients’ characteristics, presenting symptoms and expectations, by consumption of antibiotics
Total
(%)
Patients who took
antibiotics (%)a
(n = 141)
Patients who did not
take antibiotics (%)a
(n = 163)
Pick up rate % P-value b
Grouped age (years) n = 304
Less than 16 100 (33) 38 (27) 62 (38) 38 0,04*
16-59 180 (59) 90 (64) 90 (55) 50 0,13
60 and over 24 (8) 13 (9) 11 (7) 54 0,43
Gender n = 304
Female 204 (67) 95 (67) 109 (67) 47 0,93
Male 100 (33) 46 (33) 54 (33) 46
Highest education n = 302 (140/162)
Basic education (7-9 years) 34 (11) 15 (11) 19 (12) 44 0,78
High school (10-12 years) 105 (35) 50 (36) 55 (34) 48 0,75
College/university (>12 years) 163 (54) 75 (53) 88 (54) 46 0,9
Presenting symptoms n = 303 (141/162)
Sore throat 101 (33) 52 (37) 49 (30) 51 0,21
Earache 94 (31) 40 (28) 54 (33) 43 0,37
Cough 124 (41) 63 (45) 61 (37) 51 0,2
Fever 111 (37) 62 (44) 49 (30) 56 0,012*
Sinus pain 118 (39) 56 (40) 62 (38) 47 0,76
Muscular aches 32 (11) 17 (12) 15 (9) 53 0,42
Runny nose 49 (16) 22 (16) 27 (17) 45 0,82
Nasal congestion 94 (31) 39 (28) 55 (34) 41 0,25
Malaise 72 (24) 38 (27) 34 (21) 53 0,21
Wheezing/shortness of breath 61 (20) 31 (22) 30 (18) 51 0,44
Other symptoms 17 (6) 10 (7) 7 (4) 59 0,29
Sum symptoms 873 430 (3,05 pr case) 443 (2,73 pr case)
1 symptom 87 (29) 30 (21) 57 (35) 34 0,008*
2-4 symptoms 161 (53) 81 (57) 80 (49) 50 0,15
More than 4 symptoms 55 (18) 30 (21) 25 (15) 55 0,18
Feeling ill n = 301 (139/162)
Very ill 34 (11) 24 (17) 10 (6) 71 0,003*
Modestly ill 193 (64) 89 (64) 104 (64) 46 0,9
A bit ill 74 (25) 26 (19) 48 (30) 35 0,026*
Patient expectations n = 303 (141/162)
Antibiotic prescription 157 (52) 79 (56) 78 (48) 50 0,16
Other prescription 44 (15) 20 (14) 24 (15) 45 0,89
Advice 51 (17) 22 (16) 29 (18) 43 0,61
Tests 144 (48) 69 (49) 75 (46) 48 0,61
Referral 9 (3) 3 (2) 6 (4) 33 0,43
Sicknote 43 (14) 24 (17) 19 (12) 56 0,18
No expectations 50 (17) 19 (13) 31 (19) 38 0,19
Diagnosis group n = 304
Upper respiratory tract symptoms and infections 60 (20) 34 (24) 26 (16) 57 0,075
Lower respiratory tract infections 41 (14) 21 (15) 20 (12) 51 0,5
Ear infections 65 (21) 23 (16) 42 (26) 35 0,045*
Sinusitis 101 (33) 47 (33) 54 (33) 47 0,97
Acute tonsillitis 24 (8) 11 (8) 13 (8) 46 0,96
Other respiratory diagnoses 13 (4) 5 (4) 8 (5) 38 0,56
a Percentages within the brackets are those within the patient group.
b Pearson chi-square.
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12 patients (4%) felt unconfident, and the remaining 30
patients (10%) felt neither. There were no significant
correlations between confidence and certain diagnosis
or prescription pick up rate. 270 patients (89%) would
prefer to receive a wait-and-see prescription in a similar
situation in the future, nine patients (3%) would prefer
not to be offered delayed prescribing, whereas 24
patients (8%) were uncertain what they preferred.
Patients with upper RTI did to a lesser extent wish for
delayed prescribing in the future (48/60, 80%, p =
0,016).
Out of the 163 patients stating not to consume the
antibiotics, 64 (39%) reported to have saved the pre-
scription or the medication for later.
In 210 (69%) of the cases, the GPs answered that they
viewed delayed prescribing a very reasonable approach
in the specific clinical setting. In 90 cases (30%) they
found the approach fairly reasonable, and in four cases
(1%) they expressed to be uncertain on this subject.
Table 5 presents factors associated with GPs finding
delayed prescribing a reasonable strategy.
12 wait-and-see prescriptions from 10 different GPs
were issued because of disagreement with the patient. In
three of these cases (25%), the GP found the method
very reasonable, as opposed to 71% when the wait-and-
see prescription was issued for other reasons.
In sinusitis, the GPs found delayed prescribing very
reasonable in 79% of the cases. At the opposite, the GPs
Table 4 Logistic multivariate regression analysis
Unadjusted Adjusted a
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Age (years)
Less than 16 1 1
16-60 1,63 (0,99 - 2,69) 0,054 2,21 (1,25 - 3,92) 0,006
60 and over 1,93 (0,79 - 4,74) 0,15 2,89 (1,01 - 8,29) 0,048
Sex
Male 1 1
Female 1,02 (0,63 - 1,65) 0,93 0,80 (0,47 - 1,36) 0,41
Highest education
Basic education (7-9 years) 1 1
High school (-12 years) 1,15 (0,53 - 2,51) 0,72 1,19 (0,50 - 2,84) 0,7
College/university (>12 years) 1,08 (0,51 - 2,27) 0,84 1,33 (0,58 - 3,05) 0,5
Symptoms b
Sore throat 1,36 (0,84 - 2,19) 0,21
Cough 1,35 (0,85 - 2,14) 0,2
Fever 1,83 (1,14 - 2,93) 0,012 1,94 (1,15 - 3,27) 0,012
Nasal congestion 0,75 (0,46 - 1,23) 0,25 0,58 (0,34 - 0,99) 0,046
Malaise 1,4 (0,82 - 2,38) 0,21
Feeling ill
A bit ill 1 1
Modestly ill 1,58 (0,91 - 2,75) 0,11 1,46 (0,81 - 2,61) 0,21
Very ill 4,43 (1,84 - 10,67) 0,001 4,55 (1,77 - 11,75) 0,002
Patient expectations b
Antibiotic prescription 1,39 (0,88 - 2,18) 0,16
Sicknote 1,56 (0,81 - 2,98) 0,18
No expectations 0,66 (0,36 - 1,24) 0,2
Diagnosis group
Sinusitis 1
Lower respiratory tract infections 1,21 (0,58 - 2,5) 0,61
Otitis 0,63 (0,33 - 1,2) 0,16
Upper respiratory tract symptoms and infections 1,5 (0,79 - 2,86) 0,22
Tonsillitis 0,97 (0,4 - 2,38) 0,95
Other 0,72 (0,22 - 2,35) 0,58
Odds ratio for reporting to consume the antibiotics.
a The odds ratios are adjusted for the background characteristics and for the other surviving variables in the model.
b The reference value is not having the spesific symptom/expectation.
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found the method very reasonable in 49% of the lower
RTI-cases. The GPs found delayed prescribing more rea-
sonable when they thought the patient would not fill in
the prescription (p = 0.017).
Discussion
Summary of main findings
General practitioners who have been informed about the
use of wait-and-see prescriptions in RTIs, most often
use the strategy in cases of acute sinusitis and acute oti-
tis media. These are also the diagnoses for which the
GPs find the strategy most reasonable. The reported
reason for issuing a wait-and-see prescription is most
commonly uncertainty about indication for antibiotics.
Patients receiving a wait-and-see prescription are con-
fident in the decision whether to start taking the medi-
cation, and half of the patients report to consume the
antibiotics. Feeling very ill, having fever, and being more
than 16 years predict consumption of antibiotics, while
reporting nasal congestion is negatively associated with
consuming antibiotics.
Comparison with existing litterature
To our knowledge, this is the first survey on delayed
prescribing in which different diagnoses are compared,
and in which the feasability of the strategy among GPs
is measured.
We found that GPs issue wait-and-see prescription
most commonly in sinusitis and otitis. When compared
to a similar group of GPs in Norway [4], our numbers
show an over-representation of sinusitis and otitis,
which indicates that patients receiving antibiotics for
otitis or sinusitis more often will be instructed to wait
than patients receiving antibiotics for other conditions.
This may be because otitis and sinusitis are the two
conditions for which the Norwegian National Treatment
Guidelines recommend “watchful waiting” [16]. A Nor-
wegian prescription study shows that tonsilitis is the
Table 5 GPs opinion of delayed prescribing as a reasonable strategy
Total
(%)
Wait-and-see Rx very
reasonable (%)
(n = 210)
Wait-and-see Rx not
very reasonable (%)
(n = 94)
Very reasonable % P-value a
Diagnosis group n = 304
Upper respiratory tract symptoms and infections 60 (20) 35 (17) 25 (27) 58 0,044*
Lower respiratory tract infections 41 (14) 20 (10) 21 (22) 49 0,002*
Ear infections 65 (21) 50 (24) 15 (16) 77 0,12
Sinusitis 101 (33) 80 (38) 21 (22) 79 0,007*
Acute tonsillitis 24 (8) 17 (8) 7 (7) 71 0,85
Other respiratory diagnoses 13 (4) 8 (4) 5 (5) 62 0,55
GP’s reason for giving delayed prescription n = 304
Uncertainty about indication for antibiotics 211 (69) 151 (72) 60 (64) 72 0,16
Other reason 44 (14) 34 (16) 10 (11) 77 0,2
Uncertainty about diagnose 32 (11) 22 (10) 10 (11) 69 0,97
Difficulties with follow up 29 (10) 19 (9) 10 (11) 66 0,66
Disagreement with the patient 12 (4) 3 (1) 9 (10) 25 0,001*
GP’s expectation n = 304
Patient is likely to take antibiotics 51 (17) 29 (14) 22 (23) 57 0,039*
Patient is not likely to take antibiotics 131 (43) 100 (48) 31 (33) 76 0,017*
Uncertain 122 (40) 81 (39) 41 (44) 66 0,41
GP’s impression of patient’s antibiotics expectation n = 303 (209/94)
Patient expected antibiotics 73 (24) 47 (22) 26 (28) 64 0,32
Patient did not expect antibiotics 150 (50) 104 (50) 46 (49) 69 0,93
Uncertain 80 (26) 58 (28) 22 (23) 73 0,44
Grouped age (years) n = 304
Less than 16 100 (33) 69 (33) 31 (33) 69
16-59 180 (59) 124 (59) 56 (60) 69 0,98
60 and over 24 (8) 17 (8) 7 (7) 71
Gender n = 304
Female 204 (67) 139 (66) 65 (69) 68 0,61
Male 100 (33) 71 (34) 29 (31) 71
a Pearson chi-square.
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diagnosis that would most often warrant a prescription
for antibiotics, while URTI is at the other extreme [4].
This may explain why patients with tonsilitis in our
study felt less ill, and patients with URTI felt more ill,
as one could assume that the moderately ill patients
with tonsilitis would be given an immediate prescription
for antibiotics, and the moderately ill patients with
URTI would not be given antibiotics at all.
The first evidence on the advantages of delayed pre-
scribing came from studies on patients with sore throat
in the United Kingdom in 1997 [7], and the spreading
of this evidence is considered as one of the reasons why
antibiotic consumption continued to decrease in the UK
from the late 1990s and onwards [25]. However, in our
study sore throat is not a condition in which the GPs
readily give wait-and-see prescriptions. This may be due
to the widespread use of point-of-care streptococcal
throat tests in Norwegian general practice [26], and that
the GPs let the test results decide whether to prescribe
antibiotics.
In our study, 46% of the patients reported to consume
the antibiotics and 86% reported confidence in deciding
whether to take the antibiotics. These findings are simi-
lar to Edwards et al, who in a comparable British study
[22] found a consumption rate of 53%, and 87% confi-
dent patients. In both studies, fever was found as a pre-
dictor for consuming antibiotics. Fever is shown to be
the most important cue when parents take treatment
decisions on behalf of their sick child [27].
There were some interesting differences regarding
patient expectations. Fewer patients in our study
expected antibiotics (52%) compared to the findings of
Edwards et al (65%). This may be due to a real differ-
ence in antibiotic expectation, despite similar antibiotic
prescription rates in the two countries [3]. Another
explanation may be that the GPs in our study to a lesser
degree used delayed prescribing as a tool to meet
patient expectation for antibiotics. Substantially more
patients in our setting expected tests or referral (50% vs
Edwards et al: 2%). This indicates that the more wide-
spread use of point-of-care tests in our setting
compared to Edwards et al’s UK setting [28] has had an
influence on patients’ expectations.
We found differences in reported consumption rates
for the various diagnoses, and the internal variation
shows some resemblence with the results achieved in
various diagnose-specific RCTs on delayed prescribing;
35% vs 24 - 38% (otitis media) [5,6], 46% vs 31% (sore
throat) [7], 51% vs 20 - 45% (lower RTI/cough) [8,9],
and 57% vs 48% (upper RTI/common cold) [10]. The
results are understandably not directly comparable, as
the methods of issuing delayed prescriptions differ
between various studies, the diagnostic criteria varies,
and the antibiotic prescription rates [3] and the patients’
views on respiratory tract infections show great variance
between countries [29]. Nevertheless, the variance
between diagnose groups in our study may give valuable
information as the prescriptions for various conditions
were given in the same setting.
The natural course of otitis in children is a sponta-
neous recovery after a few days in approximately 80% of
the cases [30], whereas other RTIs may not have this
sudden relief. This might explain why ear infection is
the diagnose with the lowest pick up rate.
The overall satisfaction with delayed prescribing was
high both among GPs and patients. GPs consider over-
use of antibiotics a problem [31], and may feel uncom-
fortable prescribing antibiotics [32]. Thus, there is no
surprise that GPs in our study found wait-and-see pre-
scriptions most reasonable among patients who they
thought would not pick it up.
Although small numbers, our findings suggest that
GPs find delayed prescribing more reasonable in situa-
tions of clinical uncertainty rather than in situations
where patients demand antibiotics, which is in accor-
dance with the findings in a previous, qualitative study
among a similar group of GPs [13].
The GPs found delayed prescribing most reasonable in
cases of otitis and sinusitis while the strategy was less
valued in cases of upper and lower respiratory tract
infections. This may also, as suggested above, be due to
the difference in the current understanding and recom-
mended treatment of the various conditions; indication
for antibiotics in otitis and sinusitis depends partly,
according to Norwegian guidelines, on the duration of
symptoms. When it comes to bronchitis and URTI/com-
mon cold, the main recommendation is to avoid antibio-
tics altogether. This might explain why these diagnoses
were found less appropriate for delayed prescribing.
Strengths and limitations
The response rate (80%) was relatively high in compari-
son to a previous study [22]. The aim of this study was
not to explore clinical outcomes and safety of the
delayed prescribing strategy, and potential differences in
treatment outcomes for different diagnoses have not
been investigated.
This study does not allow to directly compare the use
of wait-and-see prescriptions with the use of prescrip-
tions for antibiotics to be taken immediately, since we
have no record of the latter. For illustrative means, we
have compared our findings with a reference material of
antibiotic prescriptions for RTIs during two winter
months.
The participating GPs had agreed to take part in a
study on delayed prescribing, and they might hold a
more positive view towards the strategy compared to
the relatively large group of invited GPs who did not
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participate. However, both high and low prescribers of
wait-and-see-prescriptions were represented.
As in all questionnaire surveys, our results depend on
the respondents report, and not necessarily on their
action. The patient questionnaire and information leaflet
were carefully constructed to avoid an impression that
not picking up the prescription would be the preferred
solution, so as to minimize a desirability bias. Still, the
reported antibiotics consumption rate of 46% may be a
underreporting of what actually happened.
The diagnoses referred in this study are the ones cho-
sen by the GPs. We do not know if, and to what extent,
diagnostic criteria were followed, and the diagnostic
accuracy may have varied between the different GPs.
Conclusion
Most patients and GPs are satisfied with the delayed
prescribing strategy. The patients’ age, symptoms and
malaise are more important than the diagnosis in pre-
dicting antibiotic consumption. The GP’s view of the
method as a reasonable approach depends on the
patient’s diagnosis. In our setting, delayed prescribing
seems to be a feasible strategy, especially in cases of
sinusitis and otitis. Educational efforts to promote
delayed prescribing in similar settings should focus on
these diagnoses.
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Appendix A – Participating GPs  
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Appendix B – Focus group interview guide 
Do you use wait-and-see prescriptions? Why/why not? 
 
Which patients do you offer wait-and-see prescriptions? 
 
For which diagnoses do you use wait-and-see prescriptions? 
 
In what situations do you use wait-and-see prescriptions?   
 
Which advantages / disadvantages do you experience with wait-and-see prescriptions? 
 
What patient factors determine whether you give a wait-and-see prescription? 
 
What clinical factors determine whether you give a wait-and-see prescription? 
 
What factors of the consultation/the circumstances determine whether you give a 
wait-and-see prescription? 
 
Can you tell about a spesific consultation in which you gave a wait-and-see 
prescription? 
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Appendix C – GP questionnaire 
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Appendix D – Patient questionnaire 
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Appendix E – Pop-up window 
 
 
 
 
